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“What is a weed? A plant whose virtues have not been discovered.” 
Fortune of the Republic (1878), 3 
–Ralph Waldo Emerson (1803-1882) 
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Background and Aims of Study 
Scilla nervosa is a member of the Hyacinthaceae plant family that has been naturalised in 
the grasslands of Southern Africa.  The bulbs are traditionally used to treat a variety of 
ailments.  For example, the Zulu people use aqueous decoctions of the bulbs as analgesics in 
the treatment of rheumatic fever, crushed bulbs are used by the Sotho people as laxatives and 
the Tswana people use cooked bulbs to treat infertility in women as well as cold aqueous 
extracts to treat infections.  It was recently demonstrated in our laboratory that extracts 
prepared from the bulbs possess potent anti-inflammatory properties, and this may therefore 
provide a rationale for the traditional use of the plant as an analgesic.
1
  Several studies have 
demonstrated that the bulbs contain homoisoflavanones and stilbenoids that could be 
responsible for their therapeutic effects.  Although the plant has diverse medicinal 
applications, and despite it being recognised as a poisonous species particularly in livestock, 
little is known about its toxicity in human liver cells.  The objectives of this study were 
therefore to investigate the potential toxicity of the bulbs on the liver, a major detoxifying 
organ.  A human liver cell line was treated with an aqueous extract of the bulbs to investigate 
(1) cell viability, (2) potential mechanisms of cytotoxicity, (3) DNA integrity, and (4) 
changes in the cytochrome P450 enzyme activity. 
Materials and Methods 
This study was conducted on the cultured HepG2 human hepatocellular carcinoma cell 
line, a model system to investigate the cytotoxicity of xenobiotics.  The viability of cultured 
HepG2 liver cells in the presence of varying concentrations of an aqueous extract of the bulbs 
was determined after 24 hours treatment, and the concentration that reduced viability to 50% 
(IC50) was derived.  Potential mechanisms of cytotoxicity at the IC50 were investigated.  
These included changes in metabolic activity (intracellular adenosine triphosphate (ATP) 
quantification), apoptosis induction (phosphatidylserine (PS) externalisation, caspase-8 and -
9 induction and changes in mitochondrial membrane potential), and oxidative damage via 
free radical formation (lipid peroxidation).  Genotoxicity was investigated by determining 
changes in DNA integrity (DNA fragmentation).  The ability of the extract to stimulate or 
                                                 
1
 Du Toit, K., Kweyama, A., Bodenstein, J.  2011.  Anti-inflammatory and antimicrobial profiles of Scilla 
nervosa (Burch.) Jessop (Hyacinthaceae).  South African Journal of Science, 107:96-100. 
 iv 
inhibit enzymes commonly involved with drug metabolism was investigated by determining 
cytochrome P450 3A4 (CYP3A4) activity. 
Results 
Cell-viability decreased in a concentration-dependent manner and the IC50 was determined 
as 0.03 mg/ml.  Treating the cells at the IC50 resulted in (1) a 1.2-fold increase in intracellular 
ATP levels, (2) no significant change in PS externalisation, (3) a 1.3-fold increase in caspase-
8 activity, (4) a 1.1-fold decrease in caspase-9 activity, (5) no significant change in 
mitochondrial membrane potential, (6) a 1.9-fold increase in lipid peroxidation, (7) evidence 
for genotoxicity as demonstrated by DNA fragmentation, and (8) no evidence of changes in 
CYP3A4 activity. 
Conclusion 
Results suggest that HepG2 liver cells are sensitive to an aqueous extract of the bulbs of S. 
nervosa.  The extract has the potential to (1) induce apoptosis, (2) increase oxidative stress 
and (3) cause genotoxicity in vitro. 
Keywords 
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Chapter 1. Introduction 
1.1 Dissertation Layout 
This dissertation was written as follows: 
 Chapter 1 provides a brief background on traditional medicine; the problem statement 
and motivation of why the study was necessary and why follow-up studies should be 
considered; the aim, research questions and objectives of the study; and a brief 
overview of the experimental approach that was followed in an attempt to answer the 
research questions posed. 
 Chapter 2 is a literature review on the medicinal plant Scilla nervosa, highlighting its 
botanical, geographical, conservational, chemical and medicinal properties.  It also 
contains a review of the structure and function of the liver and explains hepatotoxicity.  
In addition, a brief overview of apoptosis, oxidative stress and the cytochrome P450 
enzyme (CYP) family is provided. 
 Chapter 3 provides details of the various experimental assays that were conducted. 
 Chapter 4 deals with the results and discussion of the assays. 
 Chapter 5 provides a summary and conclusions of the main findings of the study.  It 
also lists limitations and future studies. 
 References that were used throughout the dissertation are listed alphabetically in the 
References section, with the exception of the references for the article in Appendix 1 
where they appear at the end of the chapter instead. 
 Appendix 1 is a full-length research article of the study that was submitted for 
publication. 
 Appendix 2 contains an abstract summarising additional data on the toxicological 
properties of the plant in cultured human oesophageal SNO cancer cells.  A group of 8 
undergraduate pharmacy students was assisted and trained by me to conduct 2 major 
types of experiments as part of their final-year research project.  This abstract was also 
presented at the Annual Undergraduate Research Symposium of the School of 
Pharmacy and Pharmacology by the group. 
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 Appendix 3 contains an abstract that was accepted for a podium presentation at the 6th 
International Conference on Pharmaceutical and Pharmacological Sciences (ICPPS) 
held at Coastlands Umhlanga Hotel, Durban, South Africa from 25-27 September 
2011.  The abstract was entered for the Young Scientist Competition of the South 




 form an essential part of primary health care in both rural and 
urban communities in South Africa and other developing countries (Fennell et al., 2004).  It is 
estimated that approximately 27 million South Africans are dependent on traditional 
medicine for their health care requirements.  The extensive reliance on traditional medicine 
can be attributed to their accessibility and affordability since conventional medicine is largely 
inaccessible to much of the population residing in rural areas (Light et al., 2005; Street et al., 
2008).  Although these factors do contribute to the widespread use of traditional medicine, it 
is however largely the cultural significance of traditional medicine within local communities 
that maintains their high demand (Light et al., 2005). 
South Africa possesses a unique and extensive plant diversity.  Of the more than 30 000 
South African plant species, approximately 3 000 are used medicinally and up to 500 of these 
species are informally traded in medicinal plant markets (Light et al., 2005).  Despite the 
widespread reliance on medicinal plants, their use in South Africa is currently not regulated 
and little scientific information exists regarding their safety and efficacy to support and 
rationalise their extensive use (Fennell et al., 2004; Van Vuuren, 2008).  A common 
misconception exists that traditional medicines are safe and devoid of adverse effects, 
because their use is based on the knowledge acquired within local communities during 
centuries of use.  However, studies have shown many medicinal plants to be potentially toxic 
(Fennell et al., 2004).  It is thus of great importance that these plants continue to be evaluated 
for their safety and efficacy to validate their use (Light et al., 2005). 
                                                 
2
 Traditional medicine is defined according to the World Health Organisation (WHO) as “the sum total of 
knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures 
that are used to maintain health, as well as to prevent, diagnose, improve or treat physical and mental illnesses”.  
Traditional plant medicines contain parts of plants or other plant materials as active ingredients (WHO, 2005). 
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1.3 Problem Statement 
Scilla nervosa (Burch.) Jessop (Hyacinthaceae) [=Schizocarphus nervosus (Burch.) Van 
der Merwe]
3
 is a perennial plant belonging to the Hyacinthaceae family (Louw et al., 2002) 
and is widely distributed in the grasslands of Southern Africa (Hutchings et al., 1996).  The 
plant is extensively used medicinally for a variety of ailments such as in the treatment of 
infections, nervous disorders, fractures, cancers and rheumatic fever (Abegaz, 2002; Bangani 
et al., 1999; Bisi-Johnson et al., 2010; Louw et al., 2002). 
Although it is commercially available from nurseries and is informally traded for its 
medicinal uses, there are no pharmaceutical formulations available and there is limited 
scientific information on its pharmacology and toxicity to rationalise its widespread 
traditional use.  It continues to be used medicinally despite being recognised as a poisonous 
species, as demonstrated previously, particularly in livestock (Van der Walt and Steyn, 1946).  
Little is known about its toxicity in hepatocytes and the mechanisms by which it exerts 
cellular death. 
1.4 Aim 
The aim of this study was to investigate the toxicological properties of an aqueous extract 
prepared from the bulbs of S. nervosa in a cultured human liver cell line (HepG2).  The in 
vitro scientific knowledge thus gained could support further in vivo studies to eventually 
develop a safe and effective pharmaceutical formulation.  This study on traditional medicine 
is therefore in line with the policies of the South African government and the United Nations 
which aim to promote the development, use and regulation of traditional medicine (Draft by 
the 3
rd
 African Union Conference of Ministers of Health, 2007; United Nations Secretary 
General Report on Traditional Medicine, 2002). 
1.5 Research Questions 
This study focussed specifically on the cytotoxic effects of the bulbs of S. nervosa in liver 
cells (HepG2).  Since the liver is the main site of metabolism of xenobiotics, it could be 
particularly prone to the toxic effects of traditional medicines.  It is also the major site of 
drug-drug interactions involving the cytochrome P450 enzyme family which is involved with 
drug metabolism.  Enzyme inducers may increase the metabolism of concurrently 
                                                 
3
 The official current genus and species of the plant is Scilla nervosa.  Information provided by Dr Christina 
Potgieter at the Bews Herbarium, University of KwaZulu-Natal (Pietermaritzburg Campus), is acknowledged. 
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administered drugs and therefore diminish efficacy, while enzyme inhibitors may retard 
metabolism and cause toxicity and/or pronounced side-effects.  The following research 
questions were therefore asked: 
1. Is an aqueous extract hepatotoxic? 
2. What are the mechanisms of cytotoxicity? 
3. Is there evidence of genotoxicity? 
4. Is the activity of CYP3A4 increased or inhibited? 
1.6 Objectives 
The objectives of this study were to treat a cultured human hepatocyte cell line (HepG2) 
with an aqueous extract obtained from the bulbs of S. nervosa and investigate: 
1. Cell viability. 
2. Potential mechanisms of cytotoxicity. 
3. Evidence of genotoxicity. 
4. Changes in the activity of CYP3A4. 
1.7 Experimental Approach 
The human HepG2 hepatocellular carcinoma cell line was employed as a model to study 
the toxicological properties of S. nervosa.  Cells were treated for 24 hours (h) with an 
aqueous extract previously prepared from the bulbs and viability was determined at varying 
concentrations of the extract.  This resulted in a concentration-dependent decrease in viability 
and the concentration which caused 50% reduction in viability (IC50) was deduced from the 
concentration-response curve.  After a reduction in cell viability was established, the 
mechanisms of cytotoxicity, evidence of genotoxicity and changes in activity of cytochrome 
P450 3A4 were further investigated at the IC50 (Figure 1–1). 
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Figure 1–1.  A schematic diagram depicting the experimental approach that was followed to investigate the 
toxicological properties of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) in cultured HepG2 liver cells. 
1.8 Summary and Conclusion 
Traditional medicines continue to form an integral aspect of primary health care in South 
Africa.  Scilla nervosa is an example of a medicinal plant, often used in the treatment of 
various ailments.  There is however limited scientific evidence regarding its toxicological 
properties to rationalise its extensive use.  This study therefore investigated the toxicological 
properties of this plant in human liver cells (HepG2). 
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Chapter 2. Literature Review 
This chapter provides a brief overview of Scilla nervosa, including its botany, distribution, 
conservation status, chemical constituents, medicinal uses and pharmacological activities.  
An overview of the structure and function of the liver, and hepatotoxicity is also provided.  A 
brief introduction to apoptosis and apoptotic pathways, oxidative stress, its consequences and 
antioxidants, and CYP3A4 enzymes and their modulation is presented. 
2.1 Scilla nervosa 
2.1.1 Botanical Properties 
Scilla nervosa (Burch.) Jessop (Hyacinthaceae) [=Schizocarphus nervosus (Burch.) Van 
der Merwe] is a monocotyledonous, perennial plant belonging to the Hyacinthaceae family 
(Louw et al., 2002).  The genus Scilla globally represents 80 taxa.  In Southern Africa it is 
represented by at least 4 species (Silayo et al., 1999) of which S. nervosa is the most 
widespread (Bangani et al., 1999).  This herbaceous geophyte possesses a large bulb covered 
with a sheath of bristles and leaves.  It usually has 6-12 leaves which are firm, slightly hairy 
and bright green.  It bears many greenish-yellow flowers in solitary racemes (Sener, 2003) 
(Figure 2–1). 
 
Figure 2–1.  The aerial parts of Scilla nervosa (Pacific Bulb Society, 2010). 
2.1.2 Distribution 
The plant is indigenous to Botswana but has been naturalised in the grasslands of Southern 
Africa (Hutchings et al., 1996).  It is distributed in the Eastern Cape, Free State, Gauteng, 
KwaZulu-Natal, Limpopo, Mpumalanga and North-West Provinces of South Africa (South 
African National Biodiversity Institute (SANBI), 2004). 
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2.1.3 Conservation Status 
An estimated 27 million South Africans are reliant on medicinal plants for their health 
care needs (Light et al., 2005; Mander, 1998; Street et al., 2008).  The demand for traditional 
medicine continues to increase due to the population growth.  A report by Mander (1998) 
more than 10 years ago estimated that the value of the medicinal plant trade was R500 
million per year and that the demand for medicinal plants exceeded supply.  Most medicinal 
plants are gathered from wild populations which are steadily declining in numbers due to 
their exploitation.  For example, the medicinal plant Siphonochilus aethiopicus („African 
ginger‟), which is traditionally used for coughs, colds, asthma, headache, candida infection 
and malaria (van Wyk, 2008), has been harvested to the extent that wild populations have 
almost been completely depleted (Mander, 1998).  The conservation of medicinal plants in 
South Africa is thus a growing concern as their over-utilisation presents a threat to the 
survival of many species. 
According to the Threatened Species Programme of South Africa the conservation status 
of S. nervosa is that of „Least Concern‟.  The species was evaluated against the five 
International Union for Conservation of Nature and Natural Resources (IUCN) criteria and 
did not meet the requirements for a Critically Endangered, Endangered, Vulnerable or Near 
Threatened species as it is not rare, nor is its population diminishing (SANBI, 2004).  
Although the conservation of S. nervosa is currently not under threat, the increasing demand 
and unsustainable harvesting from the wild may eventually result in its demise. 
Even though the wild population of S. nervosa has not declined to a level where it is 
considered threatened, the plant is used extensively in traditional medicine.  It would thus be 
of value to consider diverting harvesting of wild populations to controlled cultivation systems 
instead since the demise of this plant would have significant ecological and social 
consequences.  Cultivation of S. nervosa would assist in reducing the strain on wild 
populations and provide a sustainable means by which to harvest this plant. 
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2.1.4 Phytochemistry 
Previous studies on the bulbs of Scilla species have shown them to contain cardiac 
glycosides, homoisoflavanones,
4
 stilbenoids (Crouch et al., 1999) and triterpenoids (Mimaki 
et al., 1993).  Published reports on the chemical constituents of S. nervosa are however 
limited and the phytochemical profile of the whole plant is not fully known.  Previous studies 
have investigated the constituents of the bulbs. 
Phytochemical studies on the bulbs of S. nervosa by Bangani et al. (1999) yielded five 
homoisoflavanones (compounds 1-5) (Figure 2–2 and Figure 2–3).  Compounds 1-4 were of 
the 3-benzylchroman-4-one type (Figure 2–2) while compound 5 was a 3-
benzylidenechroman-4-one (Figure 2–3).  Compound 3 was isolated as its acetate (3Ac).  
Two known stilbenoids, (E)-3,4′,5-trihydroxystilbene ((E)-resveratrol) and (E)-3,3′,5-
trihydroxy-4′-methoxystilbene (rhapontigenin) were also isolated (compounds 6-7 
respectively) (Figure 2–4).  Structures were elucidated using nuclear magnetic resonance 








Compound R1 R2 R3 R4 
1 OCH3 OCH3 OCH3 H 
2 OH OCH3 OCH3 OH 
3Ac OCH3 OCH3 OCOCH3 H 
4 OH OCH3 OCH3 H 
Figure 2–2.  Compounds 1-4, homoisoflavanones of the 3-benzylchroman-4-one type that were isolated by 
Bangani et al. (1999). 
                                                 
4
 For a comprehensive review on homoisoflavanones, refer to: Du Toit, K., Drewes, S.E., Bodenstein, J.  2010.  
The chemical structures, plant origins, ethnobotany and biological activities of homoisoflavanones.  Natural 
Product Research, 24:457-490. 





Figure 2–3.  Compound 5, a homoisoflavanone of the 3-benzylidenechroman-4-one type that was isolated by 






Compound R1 R2 
6 OH H 
7 OCH3 OH 
Figure 2–4.  Compounds 6-7, stilbenoids that were isolated by Bangani et al. (1999). 
Studies by Silayo et al. (1999) yielded thirteen homoisoflavanones, nine of which were 
previously unreported (compounds 1-13) (Figure 2–5 and Figure 2–6).  Compounds 1-4 
comprised a group of 3-benzylidenechroman-4-ones (Figure 2–5), while compounds 5-13 
were found to be 3-benzylchroman-4-ones (Figure 2–6).  Three known stilbenoids, 3′,4-
dihyroxy-3,5′-dimethoxystilbene; 3,3′,5′-trihydroxy-4-methoxystilbene (rhapontigenin) and 
4,3′,5′-trihydroxy-3-methoxystilbene (isorhapontigenin) were also identified (compounds 14-
16 respectively) (Figure 2–7).  Structural elucidation was performed using high resolution 
mass spectrometry (HRMS) and NMR. 







Compound R1 R2 R3 
1 OH OCH3 OH 
2 OH OCH3 OCH3 
3 OH H OH 
4 OCH3 H OH 
Figure 2–5.  Compounds 1-4, homoisoflavanones of the 3-benzylidenechroman-4-one type that were isolated by 
Silayo et al. (1999). 







Compound R1 R2 R3 R4 R5 R6 
5 H OCH3 H OCH3 H OCH3 
6 H OCH3 H OH OCH3 OH 
7 H OH H OH OH OCH3 
8 H OCH3 OCH3 OH OCH3 OH 
9 H OH OCH3 OH H OH 
10 H OH H OH OCH3 OCH3 
11 H OCH3 OH OCH3 H OCH3 
12 H OCH3 OCH3 OCH3 H OH 
13 OH OCH3 H OCH3 H OCH3 
Figure 2–6.  Compounds 5-13, homoisoflavanones of the 3-benzylchroman-4-one type that were isolated by 
Silayo et al. (1999). 





Compound R1 R2 R3 
14 H CH3 CH3 
15 CH3 H H 
16 H CH3 H 
Figure 2–7.  Compounds 14-16, stilbenoids that were isolated by Silayo et al. (1999). 
Compound 7 (Bangani et al., 1999) and compound 15 (Silayo et al., 1999) were identical 
amongst the stilbenoids (rhapontigenin).  Amongst the homoisoflavanones, compound 3 
(Bangani et al., 1999) and compound 5 (Silayo et al., 1999) were similar 3-benzylchroman-4-
ones since compound 3 was isolated as the acetate.  In addition, compound 5 (Bangani et al., 
1999) and compound 3 (Silayo et al., 1999) were identical 3-benzylidenechroman-4-ones. 
2.1.5 Traditional Use 
The plant has been traditionally used for a variety of ailments.
5
  The bulbs of S. nervosa 
are used by the Zulu people in the treatment of nervous disorders in children, dysentery 
(Bangani et al., 1999), diarrhoea, sprains, fractures and cancers (Bisi-Johnson et al., 2010).  
Diluted bulb decoctions are used to treat pain associated with rheumatic fever.  Crushed bulbs 
are used by the Sotho people as laxatives in children (Bangani et al., 1999).  The Tswana 
                                                 
5
 For a comprehensive review on the claimed medicinal properties of traditional plants, refer to: Watt, J., 
Breyer-Brandwijk, M.  1962.  The medicinal and poisonous plants of southern and eastern Africa.  Livingston, 
Edinburgh. 
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people use cooked bulbs in porridge to treat infertility in women (Bangani et al., 1999; Silayo 
et al., 1999) and cold water extracts of the bulbs are used to treat infections (Abegaz, 2002). 
2.1.6 Pharmacological Activity 
A study by Du Toit et al. (2011) confirmed the anti-inflammatory properties and also 
demonstrated the antimicrobial activity of S. nervosa.  In a mouse model of acute croton oil-
induced auricular dermatitis, oedema was inhibited in a dose-dependent manner by 46% at 
0.1 mg and 66% at 0.5 mg of a crude methanol extract.  Differences in antimicrobial 
specificity were also observed with 2 different extracts.  Results suggested that the 
compounds present in the bulbs are individually or in combination responsible for the potent 
anti-inflammatory and antimicrobial activities. 
The pharmacological properties of the constituents present in S. nervosa have not been 
studied in detail, although studies on homoisoflavanones and stilbenoids demonstrated 
biological activity.  Previous studies have shown homoisoflavanones to possess anti-
inflammatory (Della Loggia et al., 1989; Du Toit et al., 2005), antimutagenic (Nguyen et al., 
2006; Wall et al., 1989), antihistaminic (Amschler et al., 1996), anti-angiogenic (Shim et al., 
2004) and antibacterial (Du Toit et al., 2007) activities.  Out of the 13 homoisoflavanones 
identified by Silayo et al. (1999), compounds 1, 5, 7 and 9 (Figure 2–5 and Figure 2–6) were 
sent to the National Cancer Institute, USA to be evaluated for cytotoxicity in breast and colon 
cancer cell lines.  Compound 7 was found to be the most active (ED50 = 2.24 g/ml) against 
the whole range of cell lines, while compounds 5 (6.85 g/ml) and 9 (8.06 g/ml) had 
intermediate activity and compound 1 (21.86 g/ml) was the least active (Abegaz, 2002).  
Studies on resveratrol have demonstrated its anti-inflammatory, antiviral, anticoagulant and 
cardioprotective effects, its potent anti-cancer potential (Athar et al., 2009) and its anti-
hyperglycaemic potential (Palsamy and Subramanian, 2008, 2009; Sharma et al., 2011).  
Rhapontigenin has been shown to possess cancer chemopreventative properties (Chun et al., 
2001) as well as anti-inflammatory properties through inhibition of NF-B (Kageura et al., 
2001). 
2.1.7 Toxicology 
Although S. nervosa is considered a plant of medicinal value, it has also been recognised 
as a poisonous species possibly due to the production of glycosides (Mimaki et al., 1993).  
However, no glycosides were isolated from the bulbs during phytochemical studies 
conducted by Bangani et al. (1999) and Silayo et al. (1999).  Thus it is likely that other parts 
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of the plant may contain glycosides.  The plant is considered to be particularly poisonous to 
livestock.  A study by Van der Walt et al. (1946) investigated its poisonous effects on sheep.  
A 34.1 kg and 26 kg sheep were given 1 kg and 500 g respectively of the whole plant in a 
fresh flowering state in a single dose.  Symptoms of dyspnoea, irregular pulse, apathy and an 
inactive rumen were observed before the sheep died.  A post-mortem revealed cyanosis, 
hyperaemia and oedema of the lungs as well as degenerative changes in the liver and 
myocardium.  Despite its poisonous nature, the plant is still used to treat anaplasmosis in 
cattle by the Sotho people (Bangani et al., 1999) and as a purgative for calves (McGaw and 
Eloff, 2008).  Based on the toxic effects previously observed in sheep, it was suspected that 
the plant may also be toxic to humans and was thought to cause cardiac, hepatic and renal 
toxicity (Hutchings and Terblanche, 1989; Scott, 2003).  However, there has been no 
conclusive data on the toxicity profile of the plant in humans. 
2.2 The Liver 
2.2.1 Structure of the Liver 
The liver is one of the vital organs in the body (Mitra and Metcalf, 2009).  At the cellular 
level the liver is arranged into functional units, the hepatic lobules consisting of hepatocytes.  
Blood enters the lobules through branches of the portal vein and hepatic artery and flows 
through venous sinusoids which drain into the central vein (Cunningham and Van Horn, 
2003; Planinsic and Nicolau-Raducu, 2006) (Figure 2–8). 
Hepatocytes are the major functional cells of the liver and are organised in plates.  The 
surfaces of the polygonal cells are either in contact with neighbouring cells or with the 
sinusoids.  The sinusoidal side of hepatocytes contains numerous microvilli which extend 
into bile canaliculi.  Due to the complex functions of hepatocytes, the cytoplasm is rich in 
organelles, particularly the endoplasmic reticulum which is the major site of xenobiotic 
metabolism by CYP enzymes.  Glycogen and lipid particles are also commonly present 
(Phillips et al., 1974; Zangar et al., 2004). 
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Figure 2–8.  Structure of a liver lobule (obtained with permission from Cunningham and Van Horn, 2003). 
2.2.2 Functions of the Liver 
The liver performs a multitude of functions.  The major metabolic and synthetic functions 
carried out by the liver, and in particular the hepatocytes, include carbohydrate, protein and 
lipid metabolism.  It synthesises plasma proteins, primarily albumin (Mitra and Metcalf, 
2009; Planinsic and Nicolau-Raducu, 2006).  It is responsible for the excretion of endogenous 
substances such as bilirubin, steroid hormones and exogenous substances such as drug 
metabolites.  In addition, the liver secretes bile, required for the absorption of fat and fat-
soluble vitamins in the small intestine (Mitra and Metcalf, 2009).  The immunological 
functions of the liver are exerted by the hepatic macrophages, Küpffer cells (Campbell, 
2006). 
The liver is also the primary site of metabolism of xenobiotics.  Metabolism involves 
biotransformation of the substance, resulting in its inactivation and the creation of more polar 
molecules thus allowing their excretion in the bile or urine (Campbell, 2006; Planinsic and 
Nicolau-Raducu, 2006).  Most metabolism occurs in the smooth endoplasmic reticulum via 
phase I and II reactions.  Phase I reactions inactivate drugs via oxidation, reduction or 
hydrolysis and are carried out primarily by the cytochrome P450 system.  Phase II reactions 
involve increasing the water solubility of the compounds by conjugating them with polar 
molecules such as glucuronide (Campbell, 2006). 
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2.2.3  Hepatotoxicity 
The liver is particularly prone to xenobiotic-induced hepatotoxicity due to its central role 
in xenobiotic metabolism as well as its portal circulation (Sturgill and Lambert, 1997).  Injury 
to hepatocytes may be cytotoxic (resulting in morphological changes in hepatocytes), 
genotoxic (resulting in damage to genetic material), or metabolic (causing alterations in 
cellular metabolism and mitochondrial dysfunction) (Castell et al., 1997). 
Following damage that cells are unable to recover from, hepatocytes may either undergo 
necrosis, a passive form of cell death often resulting from acute cellular injury or apoptosis, a 
highly regulated, active form of cell death (Robertson and Orrenius, 2000). 
2.3 Apoptosis 
Apoptosis or „programmed cell death‟ is a controlled, energy-dependent, genetically 
regulated form of cell death.  It plays a crucial role in the survival of organisms and is 
essential in regulating the size of cell populations, functioning and development of the 
immune system, removal of abnormal cells and maintaining tissue homeostasis (Kam and 
Ferch, 2000; Rastogi et al., 2009).  Disordered apoptosis has however been implicated in the 
pathogenesis of various diseases.  Excessive apoptosis is associated with conditions such as 
neurodegenerative diseases, immune deficiency and cardiovascular disease; conversely the 
suppression of apoptosis has been linked to cancer and autoimmune disorders (Kam and 
Ferch, 2000; Kannan and Jain, 2000; Kiechle and Zhang, 2002). 
Apoptosis occurs in a characteristic sequence of biochemical and morphological events.  
During the process, individual cells undergo a decrease in volume, externalisation of 
phosphatidylserine (PS) on the outer membrane leaflet, cell membrane blebbing, cytoskeleton 
collapse, cytoplasmic and chromatin condensation and DNA fragmentation.  The process 
culminates in the fragmentation of the cell into membrane bound apoptotic bodies which are 
phagocytosed and degraded by macrophages and other neighbouring cells without causing 
damage to the surrounding tissue.  Apoptosis does not elicit an inflammatory response 
because the cell membrane integrity of apoptotic cells is maintained and leakage of cellular 
contents is prevented (Graf et al., 2007; Kannan and Jain, 2000; Kiechle and Zhang, 2002; 
Robertson and Orrenius, 2000). 
2.3.1 Caspases 
The caspases, which represent a family of cysteine-aspartate proteases, are considered the 
central effectors of apoptosis and play essential roles in its initiation and execution.  Caspases 
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are synthesised in cells as inactive precursors, or so-called procaspases, consisting of an N-
terminal prodomain and a C-terminal protease domain (Kantari and Walczak, 2011; Lossi 
and Merighi, 2003).  Stimuli that induce apoptosis stimulate the proteolytic cleavage of 
procaspases at aspartate residues to produce activated enzymes.  Caspases that are initially 
activated trigger the activation of other downstream caspases resulting in a proteolytic 
cascade that ultimately culminates in cell death (Ashe and Berry, 2003; Ghavami et al., 
2009). 
Caspases are divided into two subsets based on their apoptotic functions.  The first group, 
initiator or so-called upstream caspases (caspase-2, -8, -9, -10), can be further divided into 
intrinsic pathway activators (caspase-9) and extrinsic pathway activators (caspase-2, -8, -10).  
These caspases undergo autoactivation prior to activating the second group, the effector or 
so-called downstream caspases (caspase-3, -6, -7), by proteolytic cleavage of the procaspases 
(Ashe and Berry, 2003; Ghavami et al., 2009; Graf et al., 2007).  Effector caspases are 
directly involved in the destruction of the cell through the cleavage of diverse cellular 
substrates (Brunelle and Zhang, 2010). 
The length and amino acid sequence of the N-terminal prodomain is highly variable 
among caspases, with initiator caspases possessing much longer prodomains compared to 
effector caspases (Ghavami et al., 2009).  Long prodomains contain specific motifs (domains) 
which are fundamental to caspase activity.  The death effector domain (DED) is found in 
caspase-8 and -10 while caspase-2 and -9 contain a caspase recruitment domain (CARD) 
(Ashe and Berry, 2003).  These domains are required to mediate interactions with adaptor 
proteins involved in cell signalling, and effector caspases (Liou et al., 2003) (Figure 2–9). 
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Figure 2–9.  A schematic diagram depicting the effector caspases (caspase-3, -6, and -7) and initiator caspases 
(caspase-2, -8, -9 and -10).  The initiator caspases contain relatively longer N-terminal prodomains, such as 
caspase-8 and -10 that contain DEDs while caspase-2 and -9 contain CARDs.  Arrows represent cleavage sites, 
and the number of amino acids is indicated.  The four surface loops (L1-L4) that shape the catalytic groove are 
shown (adapted and redrawn with permission from Riedl and Shi, 2004). 
Caspases are instrumental in producing the morphological and biochemical changes 
characteristic of apoptosis.  These enzymes are responsible for abolishing contact of 
apoptotic cells with surrounding cells, proteolysis of cytoskeleton proteins, DNA 
fragmentation, destruction of the nuclear lamina, inducing changes on the membrane surface 
to facilitate recognition by macrophages, and disintegrating apoptotic cells into apoptotic 
bodies (Kannan and Jain, 2000; Lamkanfi and Kanneganti, 2010). 
2.3.2 Apoptotic Pathways 
Apoptosis can occur via various interrelated pathways, however apoptosis can be broadly 
divided into two major cell signalling cascades (Ashe and Berry, 2003).  The pathway that is 
initiated is dependent on the nature of the inducing stimuli.  The extrinsic pathway is 
generally activated by the binding of ligands to death receptors.  The intrinsic pathway may 
be triggered by DNA damage induced by ionising radiation and anti-cancer agents, 
withdrawal of growth factors or oxidative stress (Brunelle and Zhang, 2010; Kannan and 
The toxicological properties of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) in cultured HepG2 liver cells 19 
Jain, 2000; Lamkanfi and Kanneganti, 2010).  Both pathways ultimately merge at a common 
execution pathway to produce the characteristic cellular changes associated with apoptosis 
(Ghavami et al., 2009). 
2.3.2.1 The Extrinsic Apoptotic Pathway 
The extrinsic pathway, also referred to as the death receptor pathway, is activated by the 
binding of extracellular ligands to cell surface death receptors (Brunelle and Zhang, 2010) 
(Figure 2–10).  Death receptors (DR) belong to the tumour necrosis factor receptor (TNF-R) 
gene superfamily and are characterised by an intracellular death domain of 80 amino acids 
that is necessary for transmitting apoptotic signals from the cell surface to intracellular 
signalling pathways (Fulda and Debatin, 2006).  Well-characterised death receptors include 
Fas (fibroblast associated antigen (CD95)), TNF-R1, death receptor 4 (DR4) and 5 (DR5) 
(Brunelle and Zhang, 2010) which are activated via ligation of the respective ligands, namely 
Fas ligand (FasL), tumour necrosis factor (TNF) and TNF -related apoptosis inducing 
ligand (TRAIL) (Ashe and Berry, 2003; Kantari and Walczak, 2011). 
The interaction of Fas with FasL results in the recruitment of, and association with the 
adaptor protein, Fas-associated death domain protein (FADD) (Ashe and Berry, 2003).  In 
addition to its death domain, FADD also possesses a DED which facilitates its interactions 
with the DED-containing procaspases, 8 and 10 and mediates their association with the Fas 
receptor (Hengartner, 2000).  The complex that is subsequently formed is referred to as the 
death-inducing signalling complex (DISC).  Procaspase-8 and -10 undergo self-cleavage and 
activation at the DISC to form caspase-8 and -10 (Brunelle and Zhang, 2010).  Caspase-8 
activation is regulated by cellular FLICE inhibitory protein (cFLIP) which competes with 
caspase-8 for binding to FADD at the DISC.  High concentrations of cFLIP can therefore 
diminish caspase-8 activation (Kantari and Walczak, 2011). 
If sufficient quantities of caspase-8 are activated, it is able to directly activate the downstream 
effector caspases-3, -6, and -7 (Ashe and Berry, 2003; Brunelle and Zhang, 2010).  However, 
if the amount of caspase-8 activated at the DISC is insufficient to cause the direct activation 
of effector caspases, mitochondrial amplification of death signalling occurs through the 
intrinsic pathway to mediate full caspase activation (Brunelle and Zhang, 2010; Fulda and 
Debatin, 2006).  This type of Fas signalling requires caspase-8-mediated cleavage of the BH3 
interacting domain death agonist (Bid), a member of the pro-apoptotic B-cell 
CLL/Lymphoma 2 (Bcl-2) family, to truncated Bid (tBid).  The resulting tBid translocates to 
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the mitochondria where it induces the release of pro-apoptotic factors such as cytochrome c, 
second mitochondria-derived activator of caspase/direct IAP binding protein of low 
isoelectric potential (Smac/DIABLO), apoptosis inducing factor (AIF) and endonuclease G, 
causing caspase-9 activation which subsequently activates caspase-3 (Ashe and Berry, 2003; 
Kantari and Walczak, 2011). 
Ligation of TNF-R1 by TNF stimulates the recruitment of the adaptor molecule, TNF 
receptor-associated death domain (TRADD).  FADD is subsequently recruited to the death 
receptor by TRADD and the indirect association of TNF-R1 with FADD induces apoptosis 
by a similar mechanism as Fas-mediated signalling (Ashe and Berry, 2003).  The secondary 
signalling proteins, TNF receptor-associated factor-2 (TRAF2) and receptor-interacting 
protein (RIP) are also recruited to the complex by TRADD.  TRAF2 plays an essential role in 
activating the Jun NH2-terminal kinase (JNK) pathways and NF-B (Liu et al., 1996).  While 
TNF-R1-mediated activation of JNK does not appear to be involved in the induction of 
apoptosis in most cells, the activation of NF-B has been shown to protect cells from TNF-
induced apoptosis by removal of its inhibitor I-B  (inhibitor of NF-B), allowing it to 
initiate the transcription of inhibitors of apoptosis proteins (IAPs).  The association of RIP 
with TNF-R1 induces apoptosis via the recruitment of RIP-associated ICH-1 homologous 
protein with death domain (RAIDD) which contains a CARD with which it associates with 
caspase-2 (Ashe and Berry, 2003). 
TRAIL-induced apoptosis via ligation of DR4 or DR5 occurs through the interaction with 
FADD and caspase-8 in a manner similar to Fas-mediated signalling.  Thus, caspase-8 
activation via TRAIL signalling also activates the intrinsic apoptotic pathway and 
mitochondrial amplification by a pathway similar to the one stimulated by FasL ligation.  
This mediates full caspase activation and the release of pro-apoptotic factors from the 
mitochondria (Fulda et al., 2002). 
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Figure 2–10.  The extrinsic and intrinsic pathways of apoptosis (Hengartner, 2000; obtained with permission 
from Nature Publishing Group). 
2.3.2.2 The Intrinsic Apoptotic Pathway 
The intrinsic or mitochondrial pathway is activated in response to an apoptotic signal such 
as DNA damage induced by cytotoxic drugs and oxidative stress.  The mitochondria are the 
major initiation sites of apoptosis via this pathway and play an important role in its regulation 
(Brunelle and Zhang, 2010; Hengartner, 2000) (Figure 2–10).  The intrinsic pathway is 
mediated by the release of pro-apoptotic factors from the mitochondria into the cytosol.  It is 
hypothesised that induction of mitochondrial permeability transition (MPT) and opening of 
mitochondrial permeability transition pores (PTPs) facilitates this release.  Although the 
complete structure and composition of the PTP has yet to be elucidated, it is thought to be 
composed of mitochondrial inner membrane proteins such as adenine nucleotide translocator 
(ANT) and outer membrane proteins such as voltage-dependent anion channel (VDAC).  
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These proteins act at contact sites in the inner and outer membrane to create the pores (Green 
and Reed, 1998).  Opening of these pores results in the loss of mitochondrial membrane 
potential (m) and uncoupling of oxidative phosphorylation.  An influx of fluid into the 
mitochondria has also been associated with the opening of PTPs, resulting in mitochondrial 
swelling, rupture of the mitochondrial outer membrane and the release of pro-apoptotic 
factors (Robertson and Orrenius, 2000). 
Mitochondrial apoptosis is primarily regulated by the Bcl-2 family of proteins (Kantari 
and Walczak, 2011).  It has been proposed that the release of pro-apoptotic factors from 
channels on the mitochondrial outer membrane is facilitated by these proteins (Ashe and 
Berry, 2003; Hengartner, 2000; Lossi and Merighi, 2003).  All members of this family 
contain at least one of four Bcl-2 homology (BH) domains and can be divided into three 
groups based on the number of BH domains they contain and their functions.  Bcl-2 family 
members can be first divided into anti- and pro-apoptotic members.  The anti-apoptotic 
proteins, Bcl-2, Bcl-xL, Mcl-1, Bcl-w and A1, contain all four BH domains.  Pro-apoptotic 
proteins can be further divided into two subgroups (Kantari and Walczak, 2011).  The first 
subgroup comprising Bcl-2 associated X protein (Bax), Bcl-2 homologous antagonist/killer 
(Bak) and Bcl-2 related ovarian killer (Bok) contain BH1 to BH3 domains while the second 
subgroup contains only the BH3 domain and includes the proteins Bid, Bim, Bik, Bad, Bmf, 
Hrk, NOXA and PUMA (Ashe and Berry, 2003; Kantari and Walczak, 2011). 
In response to intrinsic signals or caspase-8 in type II Fas signalling, BH3-only pro-
apoptotic proteins migrate to the mitochondria where they antagonise anti-apoptotic Bcl-2 
proteins and activate the multi-domain pro-apoptotic proteins, Bax and Bak (Launay et al., 
2005).  The release of pro-apoptotic factors into the cytosol has been attributed to various 
mechanisms.  It is proposed that Bax and Bak oligomerise and insert into the mitochondrial 
outer membrane forming pores in the membrane.  It is also thought that these pro-apoptotic 
proteins bind to the outer membrane protein, VDAC, to stimulate its opening (Ashe and 
Berry, 2003; Ghavami et al., 2009; Huerta et al., 2007; Robertson and Orrenius, 2000).  Both 
mechanisms result in the permeabilisation of the mitochondrial outer membrane and loss of 
m.  Caspase-8 cleavage of Bid to tBid also promotes permeabilisation of the 
mitochondrial outer membrane (Kantari and Walczak, 2011). 
Upon disruption of the mitochondrial outer membrane, apoptogenic proteins including 
cytochrome c, Smac/DIABLO, Omi/HtrA2, AIF and endonuclease G, which are normally 
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found in the intermembrane space of the mitochondria, are released into the cytosol (Fulda 
and Debatin, 2006).  The exact mechanism of cytochrome c is however largely unknown. 
Cytochrome c binds to the cytosolic protein, apoptotic protease-activating factor-1 
(APAF-1), and in the presence of ATP, triggers its oligomerisation and aggregation of several 
APAF-1 units (Fulda and Debatin, 2006; Ghavami et al., 2009).  The resultant effect is 
exposure of the APAF-1 CARD that induces the recruitment of procaspase-9, which is 
subsequently activated through CARD-CARD interactions (Fulda and Debatin).  The multi-
protein complex formed (consisting of cytochrome c, APAF-1, ATP and caspase-9) is termed 
the apoptosome.  Activated caspase-9 directly activates the downstream effector caspases-3, -
6 and -7 and in doing so, initiates the proteolytic cascade leading to apoptotic cell death 
(Buehrlen et al., 2007). 
Smac/DIABLO and Omi/HtrA2 enhance caspase activation by interacting with IAPs 
(Ghavami et al., 2009).  Caspase-9 activity is highly controlled by IAPs such as XIAP, 
cIAP1, cIAP2 which prevent its activation by directly binding to procaspase-9 and blocking 
its binding sites (Brunelle and Zhang, 2010; Du et al., 2000).  Smac/DIABLO and 
Omi/HtrA2 bind directly to and sequester IAPs thus antagonising their inhibitory effects 
(Ashe and Berry, 2003). 
AIF and endonuclease G induce apoptosis in a caspase-independent manner.  Both 
proteins translocate to the nucleus following permeabilisation of the mitochondrial outer 
membrane where they induce DNA fragmentation and chromatin condensation (Fulda and 
Debatin, 2006). 
The ability of medicinal plants to induce apoptosis has been extensively studied.  
Sutherlandia frutescens, which is endemic to southern Africa, is used traditionally to treat 
fever, poor appetite, wasting diseases, indigestion, gastritis, oesophagitis, peptic ulcers, 
dysentery, cancer, diabetes, colds, influenza, asthma, chronic bronchitis, kidney and liver 
conditions, rheumatism, heart failure, urinary tract infections and stress and anxiety (Van 
Wyk, 2008).  A study by Chinkwo (2005) demonstrated that an aqueous extract induced 
apoptosis in Chinese hamster ovary and cervical carcinoma cell lines.  It was hypothesised 
that apoptotic induction occurred via caspase-3 activation. 
The medicinal plant Tulbachia violacea, indigenous to the Eastern Cape, is used to treat 
fever, colds, asthma, tuberculosis and stomach problems.  In a study by Bungu et al. (2006) 
methanol extracts of the leaves and bulbs were shown to inhibit growth and induce apoptosis 
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in MCF-7, WHCO3, HT29 and HeLa cancer cell lines, although the molecular mechanisms 
involved in its action remain to be elucidated. 
2.4 Oxidative Stress 
Oxidative stress denotes an imbalance between the production of free radicals or their 
reactive metabolites (oxidants) and the antioxidant defence mechanisms in organisms (Reuter 
et al., 2010).  Free radicals are molecules containing one or more unpaired electrons that are 
capable of independent existence (Halliwell and Chirico, 1993).  They include, but are not 
limited to, reactive oxygen species (ROS), reactive nitrogen species (RNS) and sulphur-
centred radicals (Abuja and Albertini, 2001). 
Traditional plant medicines have been shown to possess both antioxidant properties as 
well as having the ability to induce ROS generation.  An aqueous extract from Sutherlandia 
frutescens was shown to possess potent antioxidant properties due to its superoxide and 
hydrogen peroxide scavenging properties (Fernandes et al., 2004). 
Conversely, Steenkamp et al. (2005) demonstrated the pro-oxidant effect of the methanol 
extract of Callilepis laureola, used traditionally to treat stomach aches, tapeworm infections, 
impotence and induce fertility, possibly due to its ability to deplete cellular glutathione. 
2.4.1 Free Radicals 
Oxygen-derived radicals have both beneficial and adverse roles in cell functioning.  ROS, 
which include superoxide (O2·
-
), hydrogen peroxide (H2O2) and the hydroxyl (OH·) free 
radical (Liu et al., 2002), are physiologically important in cell signalling mechanisms where 
they act as secondary messengers at low concentrations (Kannan and Jain, 2000).  However, 
increased production of ROS can be genotoxic or cytotoxic, capable of inducing apoptosis 
and necrosis (Shvedova et al., 2002) and has been implicated in various pathological 
conditions such as aging, neurodegenerative diseases, type II diabetes, atherosclerosis and 
ischaemia/reperfusion injury (Abuja and Albertini, 2001; Ott et al., 2007). 
The mitochondrial electron transport chain (ETC) is recognised as an important source of 
ROS generation (Chen et al., 2003; Liu et al., 2002).  The mitochondrial ETC is composed of 
a series of electron carriers arranged into 4 complexes according to their redox potentials.  
Electrons from the reducing equivalents NADH and FADH2, are transported through the ETC 
from complex I or complex II and ultimately pass to molecular oxygen (O2), generating water 
at complex IV.  However, during electron transfer some electrons leak out to O2, causing the 
one-electron reduction of O2 to produce O2·
-
 (Liu et al., 2002).  The major sites of ROS 
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generation are thought to be at complex I and complex III of the ETC (Chen et al., 2003; Liu 
et al., 2002; Ott et al., 2007) (Figure 2–11).  The superoxide anion is a precursor of most 
ROS and is quickly dismutated by manganese superoxide dismutase (Mn-SOD) to produce 
H2O2.  The subsequent interaction of H2O2 with O2·
-





of H2O2 in a Fenton reaction produces the very reactive OH· (Ott et al., 2007).  O2·
-
 may also 
react with the nitric oxide (NO) radical to produce peroxynitrite (ONOO
-
), a potent oxidant 
(Madesh and Hajnóczky, 2001). 
 
Figure 2–11.  (a) Generation of ROS in the mitochondria and (b) their inactivation by antioxidants (obtained 
with permission from Nakano et al., 2005). 
2.4.2 Antioxidants 
Both enzymatic and non-enzymatic antioxidant systems work to protect cells from the 
deleterious effects of oxidants (Reuter et al., 2010).  Enzymatic antioxidants include 
superoxide dismutase (SOD), glutathione peroxidise (GPx), glutathione reductase, 
peroxiredoxin (PRx) and catalase, while non-enzymatic antioxidants include glutathione 
(GSH), vitamin C and vitamin E.  Following the conversion of O2·
-
 to H2O2 by SOD, other 
enzymatic antioxidants catalyse its elimination (Nakano et al., 2005; Reuter et al., 2010). 
An important source of antioxidant defence comprises GSH and the various GSH-linked 
enzymes which provide protection from free radical and peroxide damage.  GPx1 and GPx4 
catalyse the reduction of H2O2 and lipid hydroperoxides to water or the appropriate alcohol 
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using GSH as an electron donor (Ott et al., 2007; Reuter et al., 2010).  GSH is then converted 
to the oxidised form, glutathione disulphide (GSSG) which is recycled to GSH by glutathione 
reductase (GR) to prevent its depletion (Nakano et al., 2005; Reuter et al., 2010) (Figure 2–
11). 
Another antioxidant defence system is the mitochondrial thioredoxin (TRX) system (Ott et 
al., 2007).  PRx is also capable of catalysing the reduction of H2O2 to water and the reduction 
of alkyl hydroperoxides to the appropriate alcohol using TRX.  Oxidised TRX is then 
recycled to TRX by TRX reductase (TR).  Both recycling processes occur in the presence of 
NADPH (Nakano et al., 2005; Reuter et al., 2010) (Figure 2–11). 
Vitamins C and E are located in extracellular fluids (Abuja and Albertini, 2001).  Vitamin 
E, a lipophilic antioxidant, is localised in the lipophilic compartment of membranes and 
lipoproteins.  It scavenges lipid peroxyl radicals to halt chain propagation during lipid 
peroxidation, and a vitamin E radical is subsequently formed.  Vitamin C is a hydrophilic 
antioxidant that scavenges aqueous radicals in the aqueous phase.  Vitamin C is also able to 
reduce the vitamin E radical and thus regenerates vitamin E, and inhibits the oxidant effects 
of the vitamin E radical (Niki et al., 2005). 
2.4.3 Consequences of Oxidative Damage 
Depletion of the antioxidant defence systems or an increase in ROS production results in 
oxidative stress (Halliwell and Chirico, 1993).  ROS may cause irreversible oxidative damage 
to proteins, nucleic acids, phospholipids and numerous other macromolecules (Grivennikova 
and Vinogradov, 2006).  Mitochondria are thought to be the major targets for the harmful 
effects of ROS as the concentration of O2·
-
 in the mitochondria appears to be higher 
compared to the cytosol and nucleus of the cell (Ott et al., 2007).  Mitochondrial membrane 
depolarisation and disruption of the ETC are prominent features leading to ROS-mediated 
cell death, particularly via the apoptotic pathway (Madesh and Hajnóczky, 2001). 
Oxidative damage to DNA may cause modification of bases, DNA strand breaks, 
abnormal DNA cross linking and mutations of proto-oncogenes and tumour suppressor genes, 
thus promoting mutagenesis (Ott et al., 2007; Reuter et al., 2010).  A particularly significant 
target of oxidative damage is the mitochondrial DNA (mtDNA), possibly due to its close 
proximity to the ROS generated via the ETC and the lack of histone proteins that protect 
DNA from injury (Wiseman and Halliwell, 1996). 
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O2·
-
 can also oxidise and inactivate iron-sulphur proteins, such as aconitases and NADH 
dehydrogenase.  The inactivation of mitochondrial aconitases would cause the release of Fe
2+
 
and H2O2.  The release of these molecules could also result in the generation of the highly 
reactive OH·.  This in turn would amplify O2·
-
-mediated oxidative damage by attacking 
mitochondrial proteins, lipids and DNA.  Mitochondrial aconitase is also essential to the 
Krebs cycle, where it is responsible for converting citrate to isocitrate.  Inactivation of this 
enzyme would cause disruption of the Krebs cycle, and as a result, negatively affect ATP 
production and cell viability (Ott et al., 2007).. 
Lipid peroxidation occurs as a result of free radicals readily attacking polyunsaturated 
fatty acids (PUFAs) such as those incorporated into cellular membrane lipids.  The highly 
reactive OH·, formed by the Fenton reaction, reacts with the single electrons contained in the 
hydrogen atoms of PUFAs.  Removal of this electron leaves behind an unpaired electron on 
the carbon atom to which it was attached.  The resulting carbon-centred lipid radical then 
undergoes molecular rearrangement prior to reacting with O2 to form peroxyl radicals 





NO, is also capable of causing lipid peroxidation possibly due to the 
decomposition of ONOO
-
 to OH· (Halliwell and Chirico, 1993).  Lipid peroxidation yields a 
variety of complex products, such as hydroperoxides and aldehydes, which may be both 
cytotoxic and genotoxic (Niki et al., 2005). 
Lipid peroxidation has numerous pathological implications.  Lipid peroxidation at the 
mitochondrial membranes affects mitochondrial functions such as oxidative phosphorylation, 
maintenance of the m, and the Ca
2+
 buffering capability of mitochondria (Ott et al., 2007).  
Intermediate and end-products formed during lipid peroxidation are also able to attack and 
damage DNA and mtDNA (Wiseman and Halliwell, 1996).  Lipid peroxidation is thus 
capable of inducing apoptotic and necrotic cell death as a result of the cellular damage it 
imparts (Tyurina et al., 2000). 
2.5 Cytochrome P450 3A4 
CYP enzymes comprise a superfamily of haeme-containing mono-oxygenases.  In 
humans, CYP enzymes which are localised in the endoplasmic reticulum (Zangar et al., 2004) 
of most tissues catalyse the oxidative metabolism of exogenous substances such as drugs, 
carcinogens and plant products as well as endogenous compounds including steroids, fatty 
acids, bile acids and prostaglandins (Mukherjee et al., 2011; Pan et al., 2010; Subehan et al., 
The toxicological properties of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) in cultured HepG2 liver cells 28 
2006).  In particular, they catalyse phase I reactions involved in the detoxification 
mechanisms in humans, where they introduce new functional groups such as hydroxyl 
groups, or modify existing functional groups on xenobiotics to create more polar compounds 
to assist phase II reactions (Westerink and Schoonen, 2007).  Although CYPs are distributed 
ubiquitously such as in the lung, nasal mucosa and vascular smooth muscle tissues, hepatic 
and intestinal CYPs play pivotal roles in xenobiotic oxidation (Mukherjee et al., 2011; 
Zangar et al., 2004). 
The CYP3A subfamily is the most abundantly expressed CYP and consists of three 
isoforms, namely CYP3A4 and CYP3A5, expressed in human adults and CYP3A7 which 
appears to be expressed primarily in foetal livers (Guengerich, 1999).  CYP3A4 is expressed 
in several extrahepatic tissues such as the lungs and small intestine, however its expression is 
most abundant in the liver where it represents approximately 50% of the total CYP content 
(Ding and Kaminsky, 2003; Pan et al., 2010). 
2.5.1 Catalytic Cycle  
The catalytic cycle of CYP3A4 and other CYPs involves the reduction and activation of 
O2.  Electrons are provided by the enzyme NADPH-P450 reductase which then oxidises 
NADPH.  The generalised cycle consists of substrate (RH) binding to the active haeme centre 
of the enzyme.  Fe
3+
 is then reduced, followed by oxygen binding, the reduction of O2, 
cleavage of the oxygen at the O-O bond which subsequently forms water, the reaction with 
the substrate at the active perferryl FeO species (FeO
3+
), and finally the release of the product 
(Guengerich, 1999; Isin and Guengerich, 2007) (Figure 2–12). 
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Figure 2–12.  The catalytic cycle of CYP3A4 (obtained with permission from Guengerich, 1999). 
2.5.2 Interactions with CYP3A4 
The substrates for CYP3A4 are structurally diverse.  Carcinogens such as aflatoxin B1 
(Hasler et al., 1999) and approximately 60% of pharmaceutical drugs (Raucy, 2003) 
metabolised by CYPs are metabolised by CYP3A4, thus interactions with this enzyme have 
both pharmacological and toxicological implications.  Drug-drug interactions that alter 
CYP3A4 activity have been well documented.  When drugs are co-administered, one drug 
may be capable of modulating the metabolism of the second drug by either inducing or 
inhibiting CYP3A4.  This could result in sub-therapeutic or toxic drug levels respectively.  
Similarly, chemical constituents from medicinal plants may also be substrates, inducers or 
inhibitors of CYP3A4 and in the same way are susceptible to changes in metabolism and may 
affect the metabolism of co-administered drugs, thereby increasing the risk of serious adverse 
reactions (Mukherjee et al., 2011).  Several medicinal plant extracts have been shown to 
interact with CYP3A4. 
The interactions of St. John‟s wort (Hypericum perforatum), a herbal preparation used in 
the treatment of mild anxiety and depression, with CYP3A4 have been extensively studied.  
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Interestingly, some components in St John‟s wort appear to inhibit CYP3A4 while others 
induce the enzyme (Moon et al., 2006; Obach, 2000).  Studies have shown the extract to 
decrease the plasma levels of drugs such as the antiretroviral drug indinavir (Piscitelli et al., 
2000) and the immunosuppressant drug cyclosporine A (Ahmed et al., 2001) due to its 
activation of CYP3A4.  The study by Obach (2000) demonstrated the ability of St. John‟s 
wort to inhibit CYP3A4 activity but no drug levels were measured. 
Several studies have also demonstrated grapefruit juice to be an inhibitor of CYP3A4, and 
have reported increased plasma levels of many drugs such as the sedative-hypnotic drug 
midazolam, the antiretroviral drug saquinavir and the calcium channel blocker verapamil 
when co-administered with grapefruit juice (Bailey et al., 1998). 
2.5.3 Modulation of CYP3A4 
CYP3A4 is prone to induction and inhibition due to its extensive substrate specificity.  
Modulation of CYP3A4 has various implications for the pharmacokinetics of drugs 
metabolised by these enzymes. 
Inhibition of CYP3A4 can lead to reduced drug clearance, prolonged effects and drug-
induced toxicity (Hasler et al., 1999; Subehan et al., 2006).  It can be broadly classified into 
reversible and irreversible inhibition.  Reversible inhibition, the more common type of 
inhibition, occurs when an inhibitor competes with the substrate for the same enzyme binding 
site and concentrations of the inhibitor are sufficient to impair enzyme activity.  Inhibition of 
the enzyme is transient and activity is restored upon diffusion of the inhibitor away from the 
enzyme.  On the other hand, irreversible inhibition or mechanism-based inhibition is caused 
by the conversion of the inhibitor to a reactive metabolite that binds covalently to the haeme 
or apoprotein of the enzyme (Hasler et al., 1999; Mukherjee et al., 2011).  Irreversible 
binding generally results in prolonged enzyme inhibition and can therefore cause severe, 
potentially fatal, adverse effects (Zhou et al., 2005). 
Conversely, induction of CYP3A4 can result in increased drug elimination, causing a 
decrease in the plasma concentration of the drug, decreased efficacy and ineffective therapy 
or treatment failure (Mukherjee et al., 2011; Tompkins and Wallace, 2007).  Alternatively, 
the increased metabolism of certain xenobiotics, including carcinogens, may lead to their 
bioactivation and the formation of reactive or toxic metabolites (Tompkins and Wallace, 
2007; Westerink and Schoonen, 2007). 
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ROS generation is a known consequence of the catalytic cycle of CYP3A4 and other 
CYPs, which involves one-electron transfer reactions.  During this cycle electrons leak out at 
various branches, causing the continuous formation of small amounts of ROS such as O2·
-
 
and H2O2 (Puntarulo and Cederbaum, 1998; Zangar et al., 2004) (Figure 2–13).  Generation 
of ROS has the potential to cause oxidative stress, lipid peroxidation and cell death.  A study 
by Puntarulo and Cederbaum (1998) investigated the ability of various CYP isoforms to 
produce ROS.  It was found that CYP3A4 was the most active in catalysing the oxidation of 
NADPH and producing O2·
-
.  Drugs that have inductive capabilities towards CYP3A4 thus 
also have the potential to increase ROS generation and their deleterious effects. 
 
Figure 2–13.  Catalytic cycle of CYP3A4 with blue arrows showing ROS-producing branches (obtained with 
permission from Zangar et al., 2004). 
2.5.4 Pregnane X Receptor 
The pregnane X receptor (PXR), an orphan nuclear receptor belonging to the nuclear 
receptor superfamily, is now thought to mediate CYP3A4 gene expression in response to 
xenobiotics.  PXR ligands include a wide variety of endogenous chemicals, such as steroid 
hormones and xenobiotics, including the tuberculocidal drug rifampicin and antifungal drug 
clotrimazole (Pascussi et al., 2001; Tompkins and Wallace, 2007).  A study by Moore et al. 
(2000) showed that hyperforin, a chemical constituent of St. John‟s wort, was a potent ligand 
of the PXR, thus providing a mechanism by which St. John‟s wort induces CYP3A4, and 
demonstrating that the PXR can also be activated by components present in plants.  Upon 
ligation, PXR translocates from the cytosol to the nucleus where it forms a heterodimer with 
the retinoid X receptor alpha (RXR) (Komoroski et al., 2004).  This complex then binds to 
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PXR response elements in the promoter region of the CYP3A4 gene, resulting in its 
activation and an increase in CYP3A4 expression (Pascussi et al., 2001; Tompkins and 
Wallace, 2007) (Figure 2–14). 
 
Figure 2–14.  A schematic representation of xenobiotic activation of the PXR, causing CYP3A4 induction 
(adapted and redrawn from Tompkins and Wallace, 2007; obtained with permission from John Wiley and Sons). 
2.6 Summary and Conclusion 
Traditional medicines are extensively used in South Africa and around the world.  S. 
nervosa is used traditionally to treat many ailments although there are no conventional 
pharmaceutical formulations available.  Scientific evidence supports its anti-inflammatory 
and antimicrobial use.  The bulbs contain several homoisoflavanones and stilbenoids which 
may be individually or in combination responsible for its anecdotal and observed therapeutic 
effects.  Little information is available to elucidate its potential toxic effects.  The liver 
performs a multitude of functions, but it is the primary site of metabolism of xenobiotics, thus 
assessing the toxicity of the extract in the liver is of particular importance.  Apoptosis and 
oxidative stress are implicated in the pathology of multiple diseases, while xenobiotics 
capable of modulating CYP3A4 are associated with drug interactions, thus investigating how 
the extract influences apoptosis, oxidative stress and CYP3A4 enzymes is significant in 
determining how the extract exerts its toxic effects. 
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Chapter 3. Materials and Methods 
This chapter provides a brief background into the various assays and describes the 
methodology and materials that were used in the preparation of the aqueous extract of S. 
nervosa, and the procedure and materials used to assess the cytotoxicity of S. nervosa, 
possible mechanisms of toxicity and its effect on CYP3A4 enzymes. 
3.1 Preparation of Aqueous Extract 
3.1.1 Introduction 
S. nervosa is primarily used traditionally as an aqueous extract, either as bulb decoctions 
or cold water extracts (Abegaz, 2002; Bangani et al., 1999).  An aqueous extract of S. 
nervosa was thus prepared to replicate the methods of the herbal practitioner and mimic the 
effects of its traditional use as close as possible. 
3.1.2 Materials and Methods 
Briefly, S. nervosa was purchased from the Fig Tree Indigenous Nursery (Westville, 
Durban, South Africa), identified, and a voucher (Du Toit2, NU) was lodged at the University 
of KwaZulu-Natal Herbarium (Pietermaritzburg, South Africa) (Du Toit et al., 2011).  All the 
plants were of the same developmental stage and were harvested at the same time (June 
2008).  This was to minimise seasonal variation and changes in metabolite content.  The fresh 
bulbs were chopped into small pieces and dried overnight.  Pieces were soaked in methanol 
(3 days) to release the polar and non-polar components of the material.  The extract thus 
obtained was filtered and dried in a rotary evaporator (Heidolph, Darmstadt, Germany).  The 
dry material thus obtained was dried a second time in the rotary evaporator at the boiling 
point of methanol to evaporate all traces of methanol (65 °C; 30 min).  Small amounts of the 
dry material that were obtained were dissolved in double distilled water through agitation 
(10-15 min).  Solubility of the material in water was determined to be 10 mg/ml.  No 
sedimentation was observed. 
3.2 HepG2 Liver Cells 
3.2.1 Introduction 
These cells are an adherent, non-tumourigenic, epithelial cell line (ATCC number HB-
8065) and were derived from the liver tissue of a 15-year-old Caucasian male with 
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hepatocellular carcinoma in 1979.  There is no evidence of a Hepatitis B virus genome in this 
cell line.
6
  The human HepG2 hepatocellular carcinoma cell line is considered a model cell 
line for the investigation of toxicity.  It retains many of the specialised functions that are 
normally lost by primary hepatocytes in culture, such as the secretion of major plasma 
proteins (Mersch-Sundermann et al., 2004). 
3.2.2 Maintenance 
HepG2 cells were resuscitated from liquid nitrogen storage by incubation at 37 °C for a 
few minutes.  The cells were then cultured to confluency in complete culture media (CCM) in 
25 cm
3
 tissue culture flasks at 5% CO2 and 37 °C.  CCM contained Dulbecco‟s modified 
Eagle‟s medium (DMEM) (Whitehead Scientific, Johannesburg, South Africa) supplemented 
with 10% (v/v) foetal bovine serum, 1% (v/v) L-glutamine and 1% (v/v) Penstrep-
Fungizone® solution (Merck, Johannesburg, South Africa).  CCM was replaced every two 
days.  Once cells were confluent, they were sub-cultured via trypsinisation according to the 
type of assay. 
3.3 Cell Viability Assay 
3.3.1 Introduction 
The cytotoxicity of S. nervosa in HepG2 cells was assessed using the methylthiazol 
tetrazolium (MTT) cellular viability assay (Mosmann, 1983).  The method is based on the 
reduction of MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide), a 
yellow tetrazolium salt, to purple formazan crystals in viable cells.  This colorimetric assay is 
extensively used as an indicator of cell viability and proliferation, since only metabolically 
active cells are capable of converting the MTT salt to formazan crystals (Bernhard et al., 
2003). 
Although the MTT assay is widely used in cell proliferation and cytotoxicity assays, the 
site of, and the biochemical events implicated in MTT reduction, remain unclear.  It was long 
believed that MTT reduction occurred in the mitochondria of living cells due to interactions 
with the respiratory chain via the succinate-dehydrogenase system (Bernhard et al., 2003).  
However, studies have since elucidated that alternative mechanisms may also be involved in 
cellular MTT reduction.  Berridge and Tan (1993) found that most cellular MTT reduction 
occurred outside the mitochondria and involved NADH- and NADPH-dependent 
                                                 
6
 Information provided by the American Type Culture Collection (ATCC; www.atcc.org). 
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mechanisms in a bone marrow-derived cell line, while a study by Dhanjal and Fry (1997) 
demonstrated that MTT reduction in rat hepatocytes was the greatest with NADH and the 
least with succinate.  Bernas and Dobrucki (2002) also showed that only 25-45% of MTT-
formazan was associated with mitochondria in HepG2 cells by imaging the formation of 
formazan deposits.  In a study by Liu et al. (1997) it was observed that in a cell line derived 
from rat brain tumours, MTT was reduced in intracellular vesicles such as endosomes and 
lysosomes.  It was also noted that MTT was absorbed by cells via endocytosis and formazan 
was transported to the cell surface via exocytosis.  Berridge et al. (1996) also showed that 
microsomal enzymes in the endoplasmic reticulum required NADH and NADPH to reduce 
MTT. 
3.3.2 Materials and Methods 
Emetine dihydrochloride was obtained from Sigma-Aldrich (St. Louis, MO, USA), MTT 
was purchased from Calbiochem (Johannesburg, South Africa).  All other reagents were 
obtained from Merck. 
The extract stock solution (10 mg/ml) was serially diluted in CCM within the range of 0-5 
mg/ml. 
Emetine, an alkaloid drug which has been reported to enhance cytotoxicity (Lee and 
Wurster, 1995) and induce apoptosis in tumour cells (Bicknell et al., 1994), was included as a 
positive control.  A stock solution of 1 mg/ml was prepared in CCM.  The stock solution was 
then serially diluted within the range of 0-300 µg/ml. 
HepG2 cells were trypsinised and seeded into a 96-well microtitre plate (15 000 cells/well) 
and treated in duplicate or triplicate with the serial dilutions of the extract or emetine for 24 h.  
Cells incubated with CCM only were used as a negative control.  Thereafter, cells were 
incubated with the MTT salt solution (5 mg/ml in phosphate buffered saline (PBS)) for a 
further 4 h.  Following this incubation, the culture fluid was aspirated from each well, 
dimethyl sulphoxide (DMSO) (100 µl/well) was added and the cells were incubated for 1 h.  
The optical density was then measured at 570 nm with a reference wavelength of 690 nm in 
an ELISA plate reader (Bio-Tek Quant).  Results were expressed as percentage cell 
viability. 
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3.3.3 Data Analysis 
The assay was performed twice to establish a concentration-response curve for the extract 
and for emetine.  The concentration at which the extract or emetine decreased cell viability to 
50% (IC50) was determined from the non-linear, sigmoidal, least-square, variable slope fits by 
using GraphPad Prism v. 5 for Windows® (GraphPad Software, San Diego, CA, USA).  Data 
was expressed as the mean  standard error of the mean (SEM). 
HepG2 cells were treated for 24 h in subsequent assays with the extract at the IC50 of cell 
viability.  It was decided to perform these assays at the IC50 of cell viability since lower 
concentrations could result in cytotoxic effects being underestimated, while higher 
concentrations could result in experimental artefacts.  An IC50 provides a workable midpoint. 
3.4 ATP Quantification Assay 
3.4.1 Introduction 
Metabolic activity in HepG2 cells treated with the extract was investigated by quantifying 
the intracellular ATP concentration.  ATP plays an essential role in the energy exchange 
required to drive cellular processes, and operates as the primary donor of free energy in all 
metabolically active cells (Crouch et al., 1993).  All living cells require ATP to survive and 
function, thus ATP quantification assays are useful tools in determining cell viability and 
cytotoxicity. 
The ATP quantification assay utilises bioluminescence to ascertain ATP levels in cells.  
The assay is based on the conversion of a luciferase-inactive derivative by ATP in the 
presence of Mg
2+
 to D-luciferin.  D-luciferin, a luciferase substrate, then reacts with the 
enzyme luciferase to produce oxyluciferin and release energy in the form of luminescence.  
This luminescent signal is directly proportional to the concentration of ATP present in the 
cells (Crouch et al., 1993; Hannah et al., 2001). 
3.4.2 Materials and Methods 
The CellTiter-Glo® assay kit was obtained from Promega (Madison, WI, USA).  All 
tissue culture reagents were obtained from Whitehead Scientific.  All other reagents were 
obtained from Merck. 
The CellTiter-Glo® reagent was prepared according to the manufacturer‟s instructions 
prior to the assay. 
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HepG2 cells were treated in 25 cm
3
 tissue culture flasks with CCM (negative control) or 
0.03 mg/ml extract in CCM and incubated (5% CO2; 37 °C; 24 h).  Thereafter, cells were 
trypsinised and seeded into a white 96-well luminometer plate in duplicate (20 000 
cells/well), followed by the addition of 10 l of the CellTiter-Glo® reagent.  The plate was 
agitated briefly to induce cell lysis and incubated in the dark (RT; 10 minutes (min)).  
Following incubation, the luminescent signal was measured on a microplate luminometer 
(Turner Biosystems, USA). 
3.4.3 Data Analysis  
Data was expressed as a change in relative light units (RLU) compared to the control and 
expressed as the mean  SEM.  Statistical analysis was performed using the student two-
tailed unpaired t test in GraphPad Prism.  A probability value (p) of less than 0.05 (p < 0.05) 
was considered statistically significant. 
3.5 Apoptotic Potential Assays 
3.5.1 Annexin-V Affinity Assay 
3.5.1.1 Introduction 
Phosphatidylserine externalisation in HepG2 cells was quantitatively detected using the 
annexin-V Affinity assay and fluorescence activated cell sorting (FACS).  The distribution of 
phospholipids in living cells is asymmetric, with the inner membrane leaflet containing 
anionic phospholipids (including PS) and the outer membrane leaflet containing mainly 
neutral phospholipids (Vermes et al., 1995).  Apoptotic cell death is characterised by several 
membrane changes, including the loss of asymmetry in cell membrane phospholipids by 
exposure of PS at the cell surface, which then serves as a signal for phagocytic recognition.  
The integrity of the cell membrane however, remains unaffected.  The externalisation of PS is 
thus an important indicator of apoptosis (Van Engeland et al., 1998). 
Annexin-V, a calcium dependent phospholipid binding protein has a high affinity for PS 
and provides a useful tool for measuring PS exposure (Vermes et al., 1995). As annexin-V is 
unable to traverse the undamaged lipid bilayer membranes of viable cells, fluorescein 
isothiocyanate-labelled (FITC) annexin-V molecules allows the detection of apoptotic cells 
by binding to PS that is available on their outer membrane leaflet (Buehrlen et al., 2007) 
(Figure 3–1). 
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Annexin-V, however, can also attach to PS in the inner membrane of necrotic cells due to 
the loss of membrane integrity in these cells.  To differentiate necrotic cells from apoptotic 
cells, cells can be additionally stained with DNA-binding dyes such as propidium iodide (PI), 
which are excluded by cells with intact membranes but can pass through necrotic cells 
(Darzynkiewicz et al., 1997). This double staining method permits the detection of viable, 
necrotic and apoptotic cells which can be differentiated by their particular staining patterns 
(Buehrlen et al., 2007). 
 
Figure 3–1.  Loss of membrane asymmetry during apoptosis.  PS molecules (solid black circles) become 
exposed at the outer membrane leaflet during apoptosis, permitting the binding of FITC-labelled annexin-V 
(adapted and redrawn from Van Engeland et al., 1998; obtained with permission from John Wiley and Sons). 
3.5.1.2 Materials and Methods 
The annexin-V-FITC staining kit was obtained from Roche Diagnostics (Penzberg, 
Germany).  All tissue culture reagents were obtained from Whitehead Scientific.  All other 
reagents were obtained from Merck. 
The annexin-V-FLUOS labelling solution was prepared prior to the assay by diluting 20 l 
of annexin-V-FLUOS labelling reagent in 1 ml of incubation buffer, followed by the addition 
of 20 l of PI solution. 
HepG2 cells were treated in 25 cm
3
 tissue culture flasks with CCM (negative control) or 
0.03 mg/ml extract in CCM and incubated (5% CO2; 37 °C; 24 h).  PS externalisation was 
detected following the incubation using the annexin-V-FLUOS staining kit according to the 
manufacturer‟s instructions.  Briefly, cells were trypsinised and transferred to polystyrene 
cytometry tubes (500 000 cells/tube), stained with 100 l of annexin-V-FLUOS labelling 
solution and incubated in the dark (RT; 15 min).  Flow cytometry analysis was carried out 
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using a FACS Calibur flow cytometer (BD Biosciences, Johannesburg, South Africa) with 
CellQuest PRO v. 4.0.2 software (BD Biosciences) at an excitation wavelength of 488 nm. 
3.5.1.3 Data Analysis 
Data was collected from 2 500 events per sample in duplicate and analysed using FlowJO 
v. 7.1 software (Tree Star, Inc., USA).  Cells were gated on the FL-1 and FL-3 channels to 
differentiate between apoptotic and necrotic cells.  Apoptotic cells were annexin-V-FITC 
positive and PI negative, while necrotic cells were annexin-V-FITC positive and PI positive.  
Data was expressed as the mean  SEM.  Statistical analysis was performed using the student 
two-tailed unpaired t test in GraphPad Prism.  A value of p < 0.05 was considered statistically 
significant. 
3.5.2 Caspase-8 and -9 Assays 
3.5.2.1 Introduction 
Caspase-8 and -9 activities in HepG2 cells treated with the S. nervosa extract were 
investigated using the Caspase-Glo® 8 and Caspase-Glo® 9 assays respectively.  Caspases 
play a fundamental role in the initiation and execution of apoptosis.  Caspases are expressed 
in almost all cell types as inactive precursors (zymogens) with an N-terminal prodomain of 
variable length (Köhler et al., 2002).  Caspase-8 and -9 are classified as initiator caspases and 
have large prodomains.  These, and other initiator caspases are activated by apoptotic stimuli 
and, in turn, cleave and activate downstream executioner caspases (Lamkanfi and 
Kanneganti, 2010). 
Luminometric evaluation of caspase activity is one method available of quantifying the 
activation of caspases and thus induction of apoptosis.  This assay involves the addition of a 
luminogenic substrate (caspase-8 cleavage site, Z-IETD; or caspase-9 cleavage site, Z-
LEHD), which is attached to aminoluciferin, and the enzyme luciferase to a cell sample.  
Following cleavage of the substrate by the respective caspases, aminoluciferin, a luciferase 
substrate, is released and reacts with luciferase in the presence of ATP and O2 to generate a 
luminescent signal.  This signal is directly proportional to the level of caspase activity present 
in the cell sample (Brunelle and Zhang, 2010). 
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3.5.2.2 Materials and Methods 
The Caspase-Glo® 8 and Caspase-Glo® 9 assay kits were obtained from Promega.  All 
tissue culture reagents were obtained from Whitehead Scientific.  All other reagents were 
obtained from Merck. 
Caspase-Glo® 8 and Caspase-Glo® 9 reagents were prepared according to the 
manufacturer‟s instructions. 
HepG2 cells were treated in 25 cm
3
 tissue culture flasks with CCM (negative control) or 
0.03 mg/ml extract in CCM and incubated (5% CO2; 37 °C; 24 h).  Thereafter, cells were 
trypsinised and seeded into a white 96-well luminometer plate in duplicate (20 000 cells/well) 
for both caspase assays, followed by the addition of 10 l of either the Caspase-Glo® 8 or 
Caspase-Glo® 9 reagent.  The plate was agitated (300-500 rpm; 30 seconds) and incubated in 
the dark (RT; 30 min).  Following incubation, the luminescence was measured on a 
microplate luminometer (Turner Biosystems, USA).  Results were expressed as RLU. 
3.5.2.3 Data Analysis 
Data was represented as a change in RLU compared to the control and expressed as the 
mean  SEM.  Statistical analysis was performed using the student two-tailed unpaired t test 
in GraphPad Prism.  A value of p < 0.05 was considered statistically significant. 
3.5.3 Mitochondrial Membrane Potential Assay 
3.5.3.1 Introduction 
The change in m of HepG2 cells was assessed using FACS and the JC-1 Mitoscreen 
assay (BD Biosciences).  m, which is essential for mitochondrial functioning, occurs due 
to the asymmetric distribution of protons and other ions on both sides of the inner 
mitochondrial membrane.  The inner side of the inner mitochondrial membrane is thus 
negatively charged (Kroemer et al., 1997).  Cationic lipophilic fluorochrome dyes, such as 
5,5′,6,6′-tetrachloro-l,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1) are frequently 
used to assess changes in m.  Mitochondria with low levels of depolarisation possess a 
negatively charged membrane potential which allows accumulation of the positively charged 
JC-1 dye within the mitochondrial matrix (Smiley et al., 1991).  When high concentrations of 
JC-1 dye are reached, in the presence of a high m (normal cells), j-aggregates are formed 
in the mitochondria.  These aggregates are associated with a large shift in its emission 
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spectra, upon excitation at 490 nm, resulting in mitochondria fluorescing red at 597 nm  
(Legrand et al., 2001; Salvioli et al., 1997) (Figure 3–2). 
Mitochondrial dysfunction was thought to occur early in apoptosis.  The disruption of the 
asymmetric ion distribution across the inner mitochondrial membrane during apoptosis 
causes a decrease in ΔΨm (Kroemer et al., 1997).  As a result, the JC-1 dye is unable to 
accumulate within the mitochondrial matrix and remains in the cytoplasm (apoptotic cells).  
When excited at 490 nm, the JC-1 dye fluoresces green in the cytoplasm at 537 nm (Legrand 
et al., 2001) (Figure 3–2). 
 
Figure 3–2.  Scatter plots of JC-1 staining in (A) control and (B) test cells.  Apoptosis was induced in the test 
cells.  JC-1 fluorescence is seen in both the FL-2 and FL-1 channels (region R1) in the control.  Only a small 
percentage of the population shows decreased fluorescence in the FL-2 channel (R2).  In the test, there is a 
significant increase in the number of cells with lowered red fluorescence in the FL-2 channel (R2), indicative of 
a change in the m and suggesting apoptosis.  JC-1 that fluoresces in both the FL-2 and FL-1 channels (red 
fluorescence) is considered to correspond to mitochondria with polarised m, while fluorescence in the FL-1 
channel and decreased fluorescence in the FL-2 channel (green fluorescence) is considered to correspond to 
mitochondria with a depolarised m (information obtained from BD Biosciences). 
The JC-1 assay provides a qualitative and quantitative method for assessing m in intact 
cells, and can be used for investigating the activities of mitochondria in apoptosis and a range 
of biological conditions (Salvioli et al., 1997). 
3.5.3.2 Materials and Methods 
The JC-1 dye was obtained from BD Biosciences.  All tissue culture reagents were 
obtained from Whitehead Scientific.  All other reagents were obtained from Merck. 
HepG2 cells were treated in 25 cm
3
 tissue culture flasks with CCM (negative control) or 
0.03 mg/ml extract in CCM and incubated (5% CO2; 37 °C; 24 h).  A change in m was 
detected subsequent to the incubation using the JC-1 Mitoscreen assay according to the 
manufacturer‟s instructions.  Briefly, cells were trypsinised and transferred to polystyrene 
cytometry tubes (500 000 cells/tube) and incubated with 150 l of the JC-1 dye (5% CO2; 37 
°C; 10 min).  Cells were then washed in JC-1 wash buffer, centrifuged (400 g; 5 min) and 
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resuspended in 300 l of flow cytometry sheath fluid.  Flow cytometry analysis was carried 
out using a FACS Calibur flow cytometer (BD Biosciences) with CellQuest PRO v. 4.0.2 
software (BD Biosciences) at an excitation wavelength of 488 nm.  Results were expressed as 
a percentage of the depolarised mitochondria contained in the cells. 
3.5.3.3 Data Analysis 
Data was collected from 2500 events per sample in duplicate and analysed using FlowJO 
v. 7.1 software (Tree Star, Inc., USA) by scatter plots.  Cells were gated to exclude debris in 
the FL-1 and FL-2 channels where JC-1 monomers and aggregates are fluorescent.  FL-1 and 
FL-2 bright were indicative of healthy, non-apoptotic cells while FL-1 bright and FL-2 dull 
indicated apoptotic cells with depolarised mitochondrial membranes.  Data was expressed as 
the mean  SEM.  Statistical analysis was performed using the student two-tailed unpaired t 
test in GraphPad Prism.  A value of p < 0.05 was considered statistically significant. 
3.6 Lipid Peroxidation Assay 
3.6.1 Introduction 
Oxidative stress caused by S. nervosa was assessed by measuring the extent of lipid 
peroxidation in HepG2 cells using the thiobarbituric acid assay.  Lipid peroxidation reactions 
are generally mediated by free radical chain reactions (Abuja and Albertini, 2001).  PUFAs 
are particularly susceptible substrates for such reactions.  Free radicals react with PUFAs to 
generate a second radical which is then free to react with other PUFAs, thus propagating a 
chain reaction (Kannan and Jain, 2000).  Following peroxidation, unstable lipid peroxides 
formed as a result of the reactions are degraded into intermediate or end products.  
Malondialdehyde (MDA) is one of several end products formed by the decomposition of lipid 
peroxidation products (Meagher and FitzGerald, 2000). 
The thiobarbituric acid assay provides a quantitative method for measuring the 
concentration of MDA and is based on the reaction of MDA with thiobarbituric acid (TBA)-
butylated hydroxytoluene.  MDA readily reacts with thiobarbituric acid to produce a red, 
fluorescent 1:2 MDA:TBA compound (Janero, 1990). 
3.6.2 Materials and Methods 
All tissue culture reagents were obtained from Whitehead Scientific.  All other reagents 
were obtained from Merck. 
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HepG2 cells were trypsinised and seeded into a 6-well tissue culture plate (150 000 
cells/well) and treated in duplicate with CCM (negative control) or 0.03 mg/ml extract (5% 
CO2; 37 °C; 24 h).  Following the incubation, 200 l of culture fluid from the wells was 
dispensed into glass tubes.  Then, 200 l of 2% (v/v) H3PO4, 400 l of 7% (v/v) H3PO4 and 
400 l of 1% (w/v) thiobarbituric acid + 0.1 mM butylated hydroxytoluene solution was also 
added to the tubes.  A positive control of 1% MDA was prepared, as well as a blank negative 
control containing 400 l of 3 mM HCl in place of the thiobarbituric acid + butylated 
hydroxytoluene solution.  The solutions were adjusted to pH 1.5 and heated in a water bath 
(100 °C; 15 min).  Solutions were then cooled to RT and 1.5 ml of butanol was added to each 
tube.  The samples from each condition were allowed to settle after vortexing, and 500 µl of 
the butanol phase from each tube was added to Eppendorf tubes and centrifuged (24 °C; 13 
200 rpm; 6 min).  Subsequent to the centrifugation, 100 l of the sample and controls was 
transferred to a 96-well microtitre plate in duplicate.  The optical density was measured at 
532 nm, with a reference wavelength of 600 nm using an ELISA plate reader (Bio-Tek 
Quant). 
3.6.3 Data Analysis 
The assay was performed twice.  Results were expressed as the mean  SEM of eight 
replicates divided by the absorption coefficient, 156 mM
-1
.  Statistical analysis was 
performed using the student two-tailed unpaired t test in GraphPad Prism.  A value of p < 
0.05 was considered statistically significant. 
3.7 Single Cell Gel Electrophoresis (Comet) Assay 
3.7.1 Introduction 
The potential genotoxic effects of S. nervosa on HepG2 cells was investigated using the 
alkaline comet assay (Singh et al., 1988), with minor modifications.  The comet assay is a 
simple, rapid and sensitive technique for measuring DNA damage and repair in mammalian 
cells (Liao et al., 2009), and is based on the ability of DNA fragments to move out of the cell 
during electrophoresis (Yusuf et al., 2000).  The earliest version of the comet assay, where 
electrophoresis was performed under neutral conditions, could only detect double-strand 
breaks in DNA.  The protocol was subsequently modified by Singh et al. (1988), to include 
unwinding of DNA under highly alkaline conditions (pH > 13), which allowed for the 
detection of double-strand breaks as well as single-strand breaks and alkali-labile sites in 
DNA (Liao et al., 2009). 
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In the alkaline comet assay, a small number of cells are embedded in an agarose gel on a 
microscope slide.  Three distinct layers of agarose are used, with the cells contained in the 
middle layer. Cells are lysed in lysis buffer to liberate DNA, and prior to electrophoresis, 
cells are incubated in alkaline electrophoresis buffer to facilitate DNA unwinding to produce 
single-stranded DNA.  Thereafter, DNA is subjected to electrophoresis which causes the 
migration of negatively charged DNA fragments towards the positive pole of the 
electrophoresis apparatus (Liao et al., 2009; Verschaeve and Van Staden, 2008). 
The results are based on the hypothesis that DNA damage caused by a genotoxic agent 
produces DNA fragmentation, either through DNA breaks, by excision-repair of damaged 
DNA, or the formation of alkali-labile sites.  The broken DNA strands released during cell 
lysis and DNA unwinding produce the comet tail during electrophoresis, while unharmed 
DNA does not migrate and remains intact in the comet head (Choucroun et al., 2001).  DNA 
can then be visualised by fluorescence microscopy after staining with a fluorescent DNA-
binding dye such as ethidium bromide (Liao et al., 2009). 
3.7.2 Materials and Methods 
Cyclophosphamide was obtained from Sigma-Aldrich (St. Louis, MO, USA).  All tissue 
culture reagents were obtained from Whitehead Scientific.  All other reagents were obtained 
from Merck. 
HepG2 cells were trypsinised and seeded into a 6-well tissue culture plate (150 000 
cells/well) and treated in duplicate with CCM (negative control) or 0.03 mg/ml extract (5% 
CO2; 37 °C; 24 h).  Cyclophosphamide, a known promutagen and DNA alkylating agent 
(Yusuf et al., 2000), was used as a positive control at a final concentration of 10 M (equals 
to 0.003 mg/ml).  Thereafter, the culture fluid of the wells was aspirated.  The cells were then 
washed 3 times in PBS, trypsinised and transferred to 15 ml Sterilin tubes.  The tubes were 
centrifuged (24 °C; 400 g; 10 min) and the supernatants aspirated.  Cells were then 
resuspended in 100 l PBS. 
Duplicate slides of cells were prepared.  Partially frosted microscope slides were covered 
with 400 l of 1% (w/v) molten low melting point (LMP) agarose (0.5 g LMP agarose 
dissolved in 50 ml PBS) toward their frosted ends.  The agarose was allowed to solidify 
under a coverslip at 4 °C for 10 min.  Then 25 l (20 000 cells) of treated cell suspensions 
and controls in PBS was mixed with 175 l of 0.5% (w/v) molten LMP agarose (0.5 g LMP 
agarose dissolved in 100 ml PBS).  After removing the coverslips, 200 l of the respective 
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cell suspensions was transferred onto the first layer of LMP agarose, the coverslips were 
replaced and the agarose was allowed to solidify at 4 °C for 10 min.  The coverslips were 
then removed and a third layer of 0.5% (w/v) molten LMP agarose was pipetted onto the 
second solidified layer.  The final layer was allowed to solidify under a coverslip at 4 °C for 
10 min.  After removal of the coverslips, the slides were submerged in freshly prepared cold 
lysis solution (2.5 M NaCl, 100 mM EDTA, 1% (v/v) Triton X-100, 10 mM Tris, pH 10, 
10% (v/v) DMSO) for 1 h at 4 °C.  Following the incubation, the slides were placed in an 
electrophoresis tank filled with electrophoresis buffer (300 mM NaOH, 1 mM Na2EDTA, pH 
13) and allowed to equilibrate for 20 min.  After the incubation, a current (300 mA; 25V) was 
applied to the tank for 35 min.  Subsequent to the electrophoresis, slides were rinsed 3 times 
with Tris buffer (0.4 M Tris, pH 7.4) for 15 min to neutralise the alkali.  The slides were then 
stained with 50 l of the fluorochrome, ethidium bromide (20 g/ml) and stored overnight at 
4 °C.  Slides were then viewed, and digital images recorded with an Olympus IX5I 
fluorescent microscope (Olympus America Inc., PA, USA). 
3.7.3 Data Analysis 
The assay was performed twice.  Image analysis was performed using the Comet Assay 
IV® software (Perspective Instruments Ltd., Suffolk, UK).  Randomly selected comets per 
slide (40 comets) were scored and 2 slides were used per condition.  The evaluation of DNA 
damage was based on four parameters, namely (1) the comet tail length (TL) (distance over 
which the DNA has migrated), (2) Olive tail moment (OTM) ((tail mean-head mean)  tail 
%DNA/100), (3) tail extent moment (TEM) (tail length  tail %DNA/100), and (4) tail length 
(TL)/head length (HL) (%).  Data was expressed as the mean  SEM.  Statistical analysis was 
performed using One-Way Analysis of Variance (ANOVA) with Bonferroni‟s Multiple 
Comparison Test in GraphPad Prism.  A value of p < 0.05 was considered statistically 
significant. 
3.8 Cytochrome P450 3A4 Assay 
3.8.1 Introduction 
The effect of S. nervosa on CYP3A4 activity in HepG2 cells was investigated using the 
P450-Glo™ assay.  CYP3A4 is a member of the CYP superfamily of haemoproteins.  This 
subfamily of CYP plays a vital role in the oxidative metabolism of xenobiotics and 
endogenous compounds in the liver and intestine (Pascussi et al., 2001).  Investigations have 
shown that approximately 60% of pharmaceutical drugs are oxidised by CYP3A4, thus 
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altered expression and activity of these enzymes by other drugs would have significant 
effects on the therapeutic outcome of drugs metabolised by them (Raucy, 2003).  
Consequently, adverse drug interactions frequently occur due to inhibition or induction of 
CYP3A4.  Assessing the effect of medicinal formulations on CYP3A4 thus provides an 
important tool for predicting drug interactions (Jarukamjorn et al., 2006). 
The P450-Glo™ 3A4 assay provides a luminescent method for quantifying CYP3A4 
activity.  The assay involves the conversion of a luminogenic CYP3A4 substrate by CYP3A4 
to luciferin.  Each substrate (luciferin-BE, luciferin-PFBE and luciferin-PPXE), a luciferase-
inactive D-luciferin derivative, is modified to contain a cleavable group.  Following cleavage 
of the substrate by CYP3A4, D-luciferin, a luciferase substrate, is released and reacts with 
luciferase to generate a luminescent signal.  This luminescent signal is directly proportional 
to the level of CYP3A4 activity (Cali et al., 2006). 
3.8.2 Materials and Methods 
The P450-Glo™ assay kit was obtained from Promega.  Dexamethasone was obtained 
from Sigma-Aldrich (St. Louis, MO, USA).  All tissue culture reagents were obtained from 
Whitehead Scientific.  All other reagents were obtained from Merck. 
Dexamethasone, a known CYP3A4 inducer (Pascussi et al., 2001), was used as a positive 
control. 
The reconstituted luciferin detection reagent and luciferin-PFBE substrate (2 mM stock 
solution) were prepared prior to the assay according to the manufacturer‟s instructions.  
HepG2 cells were trypsinised and seeded into a white 96-well luminometer plate (20 000 
cells/well) in triplicate and allowed to attach overnight.  Cells were then treated with 0.03 
mg/ml of the extract or 50 M dexamethasone in CCM and incubated (5% CO2; 37 °C; 24 h).  
The negative control received CCM only.  Following the incubation, the CCM was aspirated 
and 50 l of luciferin-PFBE substrate in CCM was added to each well such that a final 
concentration of 50 M of substrate was obtained in the wells.  Cells were then incubated 
(5% CO2; 37 °C; 4 h).  Thereafter, 50 l of luciferin detection reagent was added and allowed 
to react by briefly agitating the plate.  The plate was allowed to equilibrate in the dark (RT; 
20 min).  Luminescence was measured on a microplate luminometer (Turner Biosystems, 
USA).  Results were expressed as RLU. 
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3.8.3 Data Analysis 
Data was represented as a change in RLU compared to the negative control and expressed 
as the mean  SEM.  Statistical analysis was performed using ANOVA with Bonferroni‟s 
Multiple Comparison Test in GraphPad Prism.  A value of p < 0.05 was considered 
statistically significant. 
3.9 Summary and Conclusion 
The various assays used to investigate the toxicological properties of an aqueous extract of 
S. nervosa in a cultured human HepG2 hepatocellular carcinoma cell line were described.  
Each assay was described in terms of its background and rationale, the materials and methods 
that were used, as well as the preparation of the data and statistical analysis.  These assays 
were appropriate in an attempt to answer the scientific questions that were asked in this study. 
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Chapter 4. Results and Discussion 
The toxicological properties of S. nervosa in HepG2 cells were investigated in a series of 
experimental assays.  Cell viability was determined and potential mechanisms of cytotoxicity, 
genotoxicity and CYP3A4 activity were explored.  The results are presented and discussed 
here. 
4.1 Cell Viability 
 
Figure 4–1.  Concentration-response curves of % cell viability against varying concentrations of (A) S. nervosa 
extract (mg/ml) and (B) positive control emetine (g/ml) in HepG2 cells after 24 h treatment.  Arrows indicate 
the log IC50-values respectively from which the IC50-values were calculated. 
The viability of HepG2 cells in the presence of the extract (Figure 4–1A) or emetine 
(positive control) (Figure 4–1B) was reduced in a concentration-dependent fashion after 24 h 
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treatment and the IC50-values were calculated as 0.03  0.005 mg/ml and 1.0  0.026 g/ml 
respectively. 
At the lowest concentration the extract appeared to conserve metabolic activity, 
demonstrated by the increase in the conversion of the MTT salt to purple formazan crystals.  
The reduction of MTT may have been due to an increase in the activity of the succinate-
dehydrogenase system in the mitochondria (Berridge and Tan, 1993), but is most likely as a 
result of NADH- and NADPH-dependent mechanisms (Berridge et al., 1996), suggesting that 
the production of these reducing equivalents may have been increased.  The significantly 
reduced cell viability at higher concentrations, as evidenced by a decrease in MTT reduction, 
demonstrates an increase in the cytotoxicity of the extract. 
A similar trend was observed when the cells were treated with emetine.  This was not 
surprising since emetine has been reported to enhance cytotoxicity (Lee and Wurster, 1995), 
and induce apoptosis in tumour cells (Bicknell et al., 1994).  However, to the best of 
knowledge, the effects of emetine on the viability of HepG2 cells have not been reported 
previously.  The 30-fold difference in the IC50-values between the extract and emetine is 
noteworthy, suggesting that the extract was significantly less toxic to the cells than emetine. 
4.2 Cytotoxicity 
4.2.1 Metabolic Activity 
The intracellular ATP concentration increased significantly (p < 0.001) 1.2-fold from 5 
837 691  14 219 RLU (negative control) when compared to 6 945 318  5 592 RLU (extract 
treated cells). 
Apoptosis is an energy-driven and ATP-dependent process.  It has been demonstrated that 
ATP is essential for the execution of the final phase of apoptosis, which is characterized by 
morphological changes in the nucleus.  During Fas-mediated apoptosis, the active transport of 
large molecules across the nuclear membrane is required for the transmission of apoptotic 
death signals from the cytoplasm to the nucleus (Bradbury et al., 2000; Tsujimoto, 1997). 
Given that apoptosis is reliant on ATP for its execution, ATP levels should most likely 
have decreased in the HepG2 cells, however, slightly higher ATP levels were observed 
instead.  This occurrence suggests that S. nervosa may possess hypoglycaemic properties.  
Resveratrol, a chemical constituent previously isolated from S. nervosa has been shown to 
have anti-hyperglycaemic potential in obese and diabetic rats (Palsamy and Subramanian, 
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2008, 2009; Sharma et al., 2011).  The anti-hyperglycaemic effect is thought to be due to its 
ability to increase cellular glucose uptake and intracellular glucose transport (Szkudelski and 
Szkudelska, 2011).  This increase in glucose uptake would result in an increase in glycolysis 
and the Krebs cycle, which is responsible for the production of the reducing equivalents, 
NADH and FADH2.  Electrons from NADH and FADH2 enter the mitochondrial ETC and 
facilitate ATP production via oxidative phosphorylation.  Thus an increase in the 
concentration of these reducing equivalents would also increase the amount of electrons 
entering the ETC and subsequent ATP production.  It could also be that amino acid and fatty 
acid metabolism increased pyruvate production which enters the Krebs cycle to increase ATP 
production (Campbell, 2011).  These actions may account for the higher intracellular ATP 
concentration observed in cells treated with the extract.  To the best of knowledge, no 
information was found on the effects of homoisoflavanones and resveratrol on the 
intracellular ATP concentration in vitro.  This hypothesis should also be investigated further 
in vivo in an animal study where blood glucose levels are monitored before and after 
administration of the extract.  It could be that these compounds enhance glucose uptake via 
increased insulin secretion but this needs to be investigated further. 
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4.2.2 Apoptosis 





Figure 4–2.  The annexin-V FITC flow cytometry histograms (number of cells as a function of fluorescence) 
obtained after treating HepG2 cells with the (A & B) negative control and (C & D) the extract for 24 h. 
The results generated from the histograms (Figure 4–2) were expressed as a percentage of 
PS binding to annexin-V which was used as an indicator of the percentage PS externalisation.  
PS externalisation was not significantly different (p > 0.05) from 48.0  9.5% (negative 
control) when compared to 45.1  1.7% (extract treated cells). 
Exposure of the aminophospholipid PS occurs early in apoptosis.  PS, which is normally 
localised on the inner leaflet of the plasma membrane becomes externalised on the outer 
leaflet where it enables phagocytic recognition of the apoptotic cells by macrophages.  The 
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exposure of PS on the cell surface thus serves as a marker of apoptosis (Pelassy et al., 2000).  
Although the percentage PS externalisation between the control and extract treated cells was 
not significantly different, levels were relatively high in both conditions.  This may suggest 
that the control cells as well as the extract treated cells were undergoing apoptosis.  However, 
HepG2 cells are a transformed cell line which proliferates at a much faster rate than primary 
hepatocytes.  This may explain the generally high PS externalisation that was observed. 
4.2.2.2 Caspase-8 and -9 Activity 
Table 4–1.  Caspase-8 and -9 activities that were measured in HepG2 cells after treatment with the negative 
control and S. nervosa extract. 
Caspase Negative control (RLU) Extract (RLU) 
8 16 129  68 21 425  39 (↑ 1.3-fold; p < 0.001) 
9 492 443  2 522 440 190  1 545 (↓ 1.1-fold; p < 0.01) 
Caspase-8 is the primary initiator caspase of the extrinsic apoptotic pathway or death 
receptor pathway (Hengartner, 2000).  This pathway is initiated by the binding of 
extracellular ligands to cell surface death receptors that belong to the TNF-R gene 
superfamily.  Procaspase-8 is activated at the DISC subsequent to ligation of death receptors 
and recruitment of adaptor proteins.  Activated caspase-8 then elicits downstream apoptotic 
events by cleaving and activating the downstream effector caspases-3, -6, and -7; and can 
also cleave and activate Bid to tBid (Brunelle and Zhang, 2010; Fulda and Debatin, 2006).  
The significant increase in caspase-8 activation that was observed in the extract treated cells 
suggests that apoptosis may be modulated via the extrinsic apoptotic pathway (Table 4–1). 
Caspase-9 is the key initiator caspase of the intrinsic apoptotic pathway or mitochondrial 
pathway (Brunelle and Zhang, 2010).  Following the release of cytochrome c from the 
mitochondria into the cytosol, it triggers the oligomerisation and aggregation of several 
APAF-1 units.  Activation of caspase-9 occurs as a result of its association with APAF-1 at 
the apoptosome, a multi-protein complex formed consisting of cytochrome c, APAF-1, ATP 
and caspase-9 (Fulda and Debatin, 2006; Ghavami et al., 2009).  Activated caspase-9 then 
directly activates the downstream effector caspases-3, -6 and -7 (Buehrlen et al., 2007).  The 
slightly lower caspase-9 activity observed in the extract treated cells suggests that the 
intrinsic apoptotic pathway was not affected or induced (Table 4–1). 
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Figure 4–3.  The JC-1 flow cytometry scatter plot diagrams obtained after treating HepG2 cells with the (A & 
B) negative control and (C & D) the extract for 24 h.  For an interpretation of the results, refer to Figure 3–2. 
The results generated from the scatter plot diagrams (Figure 4–3) were expressed as a 
percentage of depolarised mitochondrial membranes.  Depolarised mitochondrial membranes 
were not significantly different (p > 0.05) from 30.5  0.9% (negative control) when 
compared to 31.2  1.2% (extract treated cells). 
Changes in m were originally thought to be an early, essential event in apoptosis with 
many studies demonstrating that changes in m precede the nuclear changes associated 
with apoptosis.  There is now, however, accumulating data that suggests that (1) the loss of 
m can be a late event in apoptosis, (2) there is no early requirement for the loss of m, 
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and that (3) the loss of m in apoptosis may be a specific feature of the cell type or 
apoptotic inducer (Ly et al., 2003).  It has also been suggested that the release of cytochrome 
c, and not a loss of m, is central to apoptosis since m has been described as increasing, 
decreasing, or remaining unchanged during cytochrome c release (Finucane et al., 1999; 
Scarlett et al., 2000). 
Although there was no significant change in mitochondrial membrane depolarisation in 
extract treated cells, this may not be the most suitable marker for apoptosis.  The fact that the 
extract did not significantly change the mitochondrial membrane depolarisation in HepG2 
cells also correlates with the slight increase in ATP production (see §4.2.1) since the m is 
the driving force in mitochondrial ATP synthesis.  A decrease in m (increased 
depolarisation) would have resulted in less ATP synthesis, which was not observed. 
4.2.3 Oxidative Damage 
The concentration of the lipid peroxidation product MDA was measured to assess the 
extent of lipid peroxidation and thus oxidative stress.  The MDA concentration increased 
significantly (p < 0.01) 2-fold from 0.2  0.03 M (negative control) when compared to 0.4  
0.03 M (extract treated cells). 
Lipid peroxidation occurs as a result of free radicals, most likely generated from the 
mitochondrial ETC, attacking PUFAs and causing damage in cellular membranes.  The 
highly reactive OH· reacts with the single electrons contained in the hydrogen atoms of 
PUFAs and removal of this electron leaves behind an unpaired electron on the carbon atom to 
which it was attached.  The resulting carbon-centred lipid radical then undergoes molecular 
rearrangement prior to becoming oxidised and forming lipid peroxides.  Lipid peroxidation 
yields a variety of complex products such as hydroperoxides and aldehydes.  MDA is one 
such aldehyde formed as a result of lipid peroxidation (Halliwell and Chirico, 1993; Niki et 
al., 2005). 
The significant 2-fold increase in the MDA concentration in extract treated cells suggests 
that lipid peroxidation was increased.  It is most likely that ROS production was increased as 
a consequence of the enhanced activity of the mitochondrial ETC, and this in turn increased 
lipid peroxidation.  In addition, the significant increase observed in the intracellular ATP 
concentration (see §4.2.1) correlates with an increase in activity of the mitochondrial ETC.  
Excessive production of ROS can be genotoxic and is also known to be capable of initiating 
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apoptosis (Shvedova et al., 2002).  Lipid peroxidation following oxidative stress also plays an 
important role in cytotoxicity via necrosis or disordered apoptosis (Tyurina et al, 2000). 
4.3 Genotoxicity 
4.3.1 DNA Integrity 







Figure 4–4.  Digital images of fluorescent cell DNA after HepG2 cells were treated with (A) negative control, 
(B) S. nervosa extract, and (C) positive control cyclophosphamide after 24 h treatment.  Microscopic 
magnifications are shown.  Arrows indicate comet heads and tails respectively.  Images are representative of 40 
random comets scored per slide, and 2 slides per condition. 
Cyclophosphamide (0.003 mg/ml) 
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Qualitative analysis of the digital images showed that cells treated with the extract (Figure 
4–4B) or cyclophosphamide (Figure 4–4C) exhibited a distinct DNA comet (head and tail) 
fragmentation pattern as evidenced by the increase in DNA migration compared to the 
control cells (Figure 4–4A).  The results for cyclophosphamide were expected since it is a 
known genotoxic drug (Yusuf et al., 2000). 
The results generated from the scoring of the comets (Figure 4–4) were evaluated in terms 
of different parameters (Figure 4–5).  Changes in these parameters of cells treated with the 
extract or cyclophosphamide when compared to the negative control are summarised (Table 
4–2). 
 
Figure 4–5.  Random comets were scored after HepG2 cells were treated with the negative control, S. nervosa 
extract, or positive control cyclophosphamide for 24 h.  DNA fragmentation was expressed in terms of the 
parameters OTM, TEM, TL (pixels) and % TL/HL.  Asterisks indicate statistically significant differences when 
compared with the corresponding parameter of the negative control (Table 4–2). 
The methods used for quantifying DNA migration and DNA damage are highly varied.  
The OTM and TL are the 2 most commonly used parameters in literature (Kumaravel and 
Jha, 2006).  A study by Kumaravel and Jha (2006) found the OTM, TL and TEM to be the 
most reliable measurements for detecting DNA damage.  In a different study, statistical 
analysis performed by Yusuf et al. (2000) on several known promutagens did not reveal a 
particular parameter among the OTM, TEM, TL, and %TL/HL that could better indicate the 
amount of DNA damage caused. 
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Table 4–2.  Changes in the OTM, TEM, TL and %TL/HL of HepG2 cells treated with the S. nervosa extract 
and positive control cyclophosphamide for 24 h when compared to the negative control. 
Parameter Extract Cyclophosphamide 
OTM ↑ 3.7-fold (p < 0.05) ↑ 9.6-fold (p < 0.01) 
TEM ↑ 9.5-fold (p > 0.05) ↑ 11.8-fold (p < 0.05) 
TL ↑ 3.4-fold (p < 0.01) ↑ 3.5-fold (p < 0.01) 
%TL/HL ↑ 2.5-fold (p < 0.05) ↑3.1-fold (p < 0.05) 
The DNA fragmentation observed in extract treated cells suggests that the extract may 
have induced genotoxicity in HepG2 cells.  ROS and ROS-mediated lipid peroxidation are 
capable of causing both genotoxicity and cytotoxicity via disordered apoptosis (Shvedova et 
al., 2002).  Thus the DNA fragmentation observed could possibly have occurred as a result of 
oxidative stress, as evidenced by increased lipid peroxidation (see §4.2.3), to DNA.  
Intermediate and end-products formed during lipid peroxidation attack and damage DNA as 
well as mtDNA due to their close proximity to this DNA (Ott et al., 2007; Wiseman and 
Halliwell, 1996).  DNA fragmentation is also a hallmark, late-stage event of apoptosis (Kam 
& Ferch, 2000). 
4.4 Metabolism 
4.4.1 Cytochrome P450 3A4 Activity 
Table 4–3.  CYP3A4 activity in HepG2 cells treated with the S. nervosa extract and positive control 
dexamethasone for 24 h when compared to the negative control. 
Negative control (RLU) Extract (RLU) Dexamethasone (RLU) 
2 252  96.5 2 694  193.4 (↑ 1.2-fold; p > 0.05) 2 263  21.0 (p > 0.05) 
Results indicate that the extract and dexamethasone increased the activity of CYP3A4 by 
1.2-fold and minimally respectively, and in both cases statistical significance was not 
reached. 
Previous studies have shown that HepG2 cells express low levels of CYPs, including 
CYP3A4, compared to primary human hepatocytes (Hasler et al., 1999; Westerink and 
Schoonen, 2007).  The possibility thus exists that the ability of compounds to induce 
CYP3A4 may be underestimated in studies utilising HepG2 cells when compared to primary 
human hepatocytes. 
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Primary human hepatocytes are considered the preferred in vitro model to study 
xenobiotic biotransformation due to their resemblance to the human liver compared to HepG2 
cells.  However, primary human hepatocytes are difficult to obtain due to ethical 
considerations, isolation can be complex and time consuming, cells may be damaged during 
isolation and the availability of human livers is limited.  In addition, primary hepatocytes do 
not proliferate and generally lose their metabolic activity after a few passages (splitting and 
re-seeding).  Although HepG2 cells are less suitable to predict xenobiotic metabolism, they 
are easier to culture and provide a consistently reproducible model for studying xenobiotic 
toxicity (Brandon et al., 2003; Wilkening et al., 2003) (see §3.2). 
The IC50 concentration of the aqueous extract was assessed for its ability to induce 
CYP3A4 activity.  This concentration may have been too low to induce CYP3A4 activity in 
HepG2 cells, bearing in mind that HepG2 cells minimally express this isozyme.  Thus 
although the extract did not significantly induce CYP3A4 at the IC50, this does not exclude 
the possibility that it is capable of modulating these enzymes. 
Dexamethasone induction of CYP3A4 is well documented, however the mechanism by 
which this induction occurs is not fully understood, with many studies presenting conflicting 
data (Pascussi et al., 2001).  Induction of CYP3A4 by xenobiotics is thought to be largely due 
to xenobiotic activation of the PXR (Tompkins and Wallace, 2007).  A study by Luo et al. 
(2002) demonstrated that dexamethasone weakly activated the PXR and thus weakly induced 
CYP3A4 in primary human hepatocytes.  The low expression of CYP3A4 in HepG2 cells 
may thus have also contributed to the negligible induction observed after dexamethasone 
treatment. 
4.5 Summary and Conclusion 
The results demonstrate that an aqueous extract of S. nervosa was cytotoxic to HepG2 
cells and reduced cell viability in a concentration dependent manner (IC50 = 0.03 mg/ml).  In 
assessing mechanisms of toxicity, it was found that the extract significantly increased 
intracellular ATP levels and caspase-8 activity and significantly decreased caspase-9 activity, 
suggesting the potential for the extract to induce apoptosis, specifically via the extrinsic 
apoptotic pathway.  The extract did not significantly affect PS externalisation, possibly due to 
the rapid proliferation of HepG2 cells and did not significantly change mitochondrial 
membrane potential which corresponds to the increased ATP concentration.  The 
significantly higher MDA levels indicated that the extract caused free radical-mediated lipid 
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peroxidation and oxidative stress and caused genotoxicity as evidenced by DNA 
fragmentation, possibly as a result of lipid peroxidation.  The extract marginally increased 
CYP3A4 activity although it was not statistically significant.  This could be due to the low 
expression levels of CYP3A4 in HepG2 cells. 
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Chapter 5. Summary, Conclusions and Limitations 
5.1 Summary 
1. Traditional medicine continues to form an integral aspect of primary health care in 
South Africa.  Scilla nervosa is such a medicinal plant, used in the treatment of various 
ailments.  There is however limited scientific evidence regarding its toxicological 
properties to rationalise its extensive use. 
2. The bulbs of S. nervosa contain several homoisoflavanones and stilbenoids which may 
be individually, or in combination, responsible for its anecdotal and observed 
therapeutic effects. 
3. The liver performs a multitude of functions, but it is the primary site of metabolism of 
xenobiotics, thus assessing the toxicity of the extract in the liver is of particular 
importance.  Apoptosis and oxidative stress are implicated in the pathology of multiple 
diseases, while xenobiotics, capable of modulating CYP3A4, are associated with drug 
interactions.  Therefore, investigating how the extract influences apoptosis, oxidative 
stress and CYP3A4 enzymes is significant in determining how the extract exerts its 
toxic effects. 
4. Various assays were used to investigate the toxicological properties of an aqueous 
extract of S. nervosa in a cultured human HepG2 hepatocellular carcinoma cell line. 
5. HepG2 cells were sensitive to the extract. 
5.2 Conclusions 
1. There was evidence that an aqueous extract was hepatotoxic in vitro. 
2. It has the potential to induce apoptosis via the extrinsic apoptotic pathway. 
3. There was evidence of genotoxicity, possibly as a result of oxidative stress. 
4. CYP3A4 activity was slightly elevated.  This finding was not statistically significant. 
5.3 Limitations 
1. The results of this study were obtained from a cancer cell line that is considered a 
model cell line for the investigation of toxicity.  However, results may be different in 
primary hepatocytes and it could be difficult to extrapolate the effects. 
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2. HepG2 cells were treated for 24 h and the results could have been different if shorter 
or longer periods were chosen. 
5.4 Future Studies 
1. Besides the liver, the kidneys as major excretory organs may also be prone to the toxic 
effects of traditional medicine.  The extract was not tested in kidney cell lines. 
2. The immune system may be adversely affected by traditional medicine, for example 
hypersensitivity reactions and immunosuppression may occur.  The extract was not 
tested in lymphocytes to determine changes in inflammatory mediators for example. 
3. The extract was not tested to determine neurotoxicity, carcinogenicity, teratogenicity 
and haematological effects. 
4. The pharmacokinetic parameters of traditional medicine may be complex and various 
factors could influence the bioavailability, absorption, concentration in the plasma and 
tissues, distribution, metabolism and excretion.  The therapeutic concentration, 
therapeutic window and therapeutic index are yet unknown.  This study only 
investigated the toxicological properties in vitro and there may be differences in vivo. 
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Abstract 
Bulbs of Scilla nervosa, a medicinal plant indigenous to Southern Africa, are traditionally 
used in aqueous decoctions to treat a diverse range of illnesses.  However, little information 
is known about the plant‟s toxicity on the liver, a major detoxifying organ.  This study 
investigated the effects of an aqueous extract of the bulbs in cultured HepG2 liver cells, a 
model system for investigating the toxicity of xenobiotics.  Cell viability was measured to 
obtain an IC50-value and potential mechanisms of toxicity were investigated as changes in 
metabolic activity, apoptosis, oxidative damage and DNA fragmentation using the IC50.  In 
addition, cytochrome P450 3A4 (CYP3A4) activity, which is implicated in drug metabolism 
and interactions was also assayed.  Results suggest that liver cells are sensitive to an aqueous 
extract of the bulbs and at 50% reduction in viability there is an increased potential to induce 
apoptosis and genotoxicity, and some evidence of increased CYP3A4 activity. 
Keywords 
Scilla nervosa; traditional medicine; HepG2 liver cells; caspase; apoptosis; genotoxicity; 
CYP3A4 
Introduction 
Scilla nervosa (Burch.) Jessop (Hyacinthaceae) [=Schizocarphus nervosus (Burch.) Van 
der Merwe] is a monocotyledonous perennial plant originally endemic to Botswana but has 
now been naturalised in the grasslands of the eastern parts of Southern Africa (Hutchings, 
Scott, Lewis, & Cunningham, 1996).  The bulbs of the plant have been used by traditional 
healers of different cultures and the plant is considered to be a valuable medicinal species 
(Watt & Breyer-Brandwijk, 1962).  It has been recently demonstrated in our laboratory that 
extracts prepared from the bulbs possess potent anti-inflammatory properties and these 
findings may therefore rationalise the traditional use of the plant as an analgesic for 
rheumatic fever (Du Toit, Kweyama, & Bodenstein, 2011).  Previous studies on the bulbs 
have revealed that they contain homoisoflavanones and stilbenoids (Bangani, Crouch, & 
Mulholland, 1999; Silayo, Ngadjui, & Abegaz, 1999).  These could individually or in 
combination be responsible for its therapeutic effects.  However, little information is known 
about the plant‟s toxicity and only one previous report suggested that 0.5-1 kg of the fresh 
plant in the flowering stages was toxic to sheep (Van der Walt & Steyn, 1946).  Therefore, a 
current investigation of the potential toxicity of the bulbs on the liver, a major detoxifying 
organ, is required.  The aim of the present study was to investigate the toxic effects of an 
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aqueous extract prepared from the bulbs in HepG2 liver cells, a model system for 
investigating the toxicity of xenobiotics.  Specific objectives were as follows: 
1. The viability of HepG2 cells in the presence of varying concentrations of the extract 
was investigated to determine the IC50-value. 
2. The IC50 was used as a reference concentration to investigate the potential mechanisms 
of toxicity by determining changes in: 
 Metabolic activity (intracellular ATP levels). 
 Apoptosis (phosphatidylserine externalisation; caspase-8 and -9 activity; and 
mitochondrial membrane depolarisation). 
 Oxidative stress through free radical-mediated lipid peroxidation. 
 DNA integrity. 
3. CYP isozymes are often implicated in drug-liver-drug interactions.  CYP3A4 activity 
was investigated to determine induction or inhibition. 
Results and Discussion 
Cell Viability 
The viability of HepG2 cells decreased in a concentration-dependent manner with 
increasing concentrations of extract (IC50 = 0.03  0.005 mg/ml) or emetine (IC50 = 1.0  
0.026 g/ml). 
Results suggest that the extract was significantly less cytotoxic than emetine to the HepG2 
cells (IC50 ratio = 30). 
Intracellular ATP Concentration 
The intracellular ATP concentration increased 1.2-fold (p < 0.001) from 5 837 691  14 
219 RLU (negative control) when compared to 6 945 318  5 592 RLU (extract treated cells). 
Given that apoptosis is reliant on ATP for its execution (Tsujimoto, 1997), ATP levels 
should most likely have decreased in the HepG2 cells, however, slightly higher ATP levels 
were observed instead.  This occurrence suggests that the bulbs may possess hypoglycaemic 
properties.  Resveratrol, a chemical constituent previously isolated has been shown to have 
anti-hyperglycaemic potential in obese and diabetic rats (Sharma et al., 2011).  The anti-
hyperglycaemic effect is thought to be due to its ability to increase cellular glucose uptake 
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and intracellular glucose transport (Szkudelski & Szkudelska, 2011).  The increase in glucose 
uptake would result in an increase in glycolysis and the Krebs cycle, and subsequent 
increased ATP production via oxidative phosphorylation (Campbell, 2011).  This action may 
account for the higher intracellular ATP concentration observed in the extract treated cells. 
Phosphatidylserine Externalisation 
Phosphatidylserine externalisation was not significantly different (p > 0.05) from 48.0  
9.5% (negative control) versus 45.1  1.7% (extract treated cells). 
Exposure of this aminophospholipid occurs early in apoptosis.  Phosphatidylserine is 
normally localised on the inner leaflet of the plasma membrane and becomes externalised on 
the outer leaflet where it enables phagocytic recognition of apoptotic cells by macrophages.  
Its exposure on the cell surface thus serves as a marker of apoptosis (Pelassy, Breittmayer, & 
Aussel, 2000).  Although the percentage externalisation between the control and extract 
treated cells was not significantly different, levels were relatively high in both conditions.  
This may suggest that the control cells as well as the extract treated cells were undergoing 
apoptosis.  However, HepG2 cells are a transformed cell line which proliferates at a much 
faster rate than primary hepatocytes which may explain the generally high externalisation that 
was observed. 
Caspase-8 and -9 Activity 
Caspase-8 is the primary initiator caspase of the extrinsic apoptotic pathway or death 
receptor pathway (Hengartner, 2000).  This pathway is initiated by the binding of 
extracellular ligands to cell surface death receptors that belong to the tumour necrosis factor 
TNF-R gene superfamily.  The significant increase in caspase-8 activation that was observed 
in the extract treated cells suggests that apoptosis may be modulated via the extrinsic 
apoptotic pathway (Table 1). 
Caspase-9 is the key initiator caspase of the intrinsic apoptotic pathway or mitochondrial 
pathway (Brunelle & Zhang, 2010).  The slightly lower caspase-9 activity observed in the 
extract treated cells suggests that the intrinsic apoptotic pathway was not affected or induced 
(Table 1). 
Mitochondrial Membrane Potential 
The number of depolarised mitochondria were not significantly different (p > 0.05) from 
30.5  0.9% (negative control) versus 31.2  1.2% (extract treated cells). 
The toxicological properties of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) in cultured HepG2 liver cells 81 
Changes in mitochondrial membrane potential (m) were originally thought to be an 
early, essential event in apoptosis with many studies demonstrating that these changes 
precede the nuclear changes associated with apoptosis.  There is now, however, accumulating 
data that suggests that the m may increase, decrease, or remain unchanged during 
apoptosis (Ly, Grubb, & Lawen, 2003). 
Although there was no significant change in mitochondrial membrane depolarisation in 
extract treated cells, this may not be a suitable marker for apoptosis.  The fact that the extract 
did not significantly change the mitochondrial membrane depolarisation in HepG2 cells also 
correlates with the slight increase in ATP production, since the mitochondrial membrane 
potential is the driving force in mitochondrial ATP synthesis. 
Lipid Peroxidation 
The malondialdehyde concentration increased 2-fold (p < 0.01) from 0.2  0.03 M 
(negative control) versus 0.4  0.03 M (extract treated cells). 
Lipid peroxidation occurs as a result of free radicals, most likely generated from the 
mitochondrial electron transport chain, attacking polyunsaturated fatty acids and causing 
damage in cellular membranes.  Malondialdehyde is an aldehyde formed as a result of lipid 
peroxidation (Halliwell & Chirico, 1993). 
The significant 2-fold increase in the MDA concentration in extract treated cells suggests 
that lipid peroxidation was increased.  This could be genotoxic and may initiate apoptosis 
(Shvedova et al., 2002). 
Genotoxicity 
Cells treated with the extract or cyclophosphamide exhibited a distinct DNA comet (head 
and tail) fragmentation pattern as evidenced by the increase in DNA migration compared to 
the control cells. 
The results generated from the scoring of the comets were evaluated for changes in DNA 
integrity when compared to the negative control (Table 2). 
Analysis performed by Yusuf, Vian, Sabatier, and Cano (2000) on several known 
promutagens did not reveal a particular parameter among the Olive tail moment, tail extent 
moment, tail length and % tail length/head length that could better indicate the amount of 
DNA damage caused. 
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The DNA fragmentation observed in extract treated cells suggests that the extract may 
have induced genotoxicity in HepG2 cells.  Reactive oxygen species-mediated lipid 
peroxidation is capable of inducing cytotoxicity, genotoxicity and apoptosis (Shvedova et al., 
2002).  DNA fragmentation is also a hallmark, late-stage event of apoptosis (Kam & Ferch, 
2000). 
CYP3A4 Activity 
Results indicate that the extract and dexamethasone increased the activity of CYP3A4 by 
1.2-fold and minimally respectively, and in both cases statistical significance was not reached 
(Table 3). 
Previous studies have shown that HepG2 cells express low levels of CYPs, including 
CYP3A4, compared to primary human hepatocytes (Westerink & Schoonen, 2007).  The 
concentration at which the extract was assessed for its ability to induce CYP3A4 was at the 
IC50 of cell viability.  It may have occurred that this concentration was too low to induce 
CYP3A4 in HepG2 cells.  Thus, although the extract did not significantly induce CYP3A4 at 
the IC50, this does not exclude the possibility that it is capable of modulating these enzymes. 
Dexamethasone induction of CYP3A4 is well documented, however the mechanism by 
which this induction occurs is not fully understood, with many studies presenting conflicting 
data (Pascussi et al., 2001).  Induction of CYP3A4 by xenobiotics is thought to be largely due 
to xenobiotic activation of the pregnane X receptor (Tompkins & Wallace, 2007).  A study by 
Luo et al. (2002) demonstrated that dexamethasone weakly activated this receptor and thus 
weakly induced CYP3A4 in primary human hepatocytes. 
Experimental 
Chemicals 
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was obtained 
from Calbiochem (Johannesburg, South Africa) and emetine dihydrochloride from Sigma (St 
Louis, MO, USA).  All tissue culture reagents were obtained from Whitehead Scientific 
(Johannesburg, South Africa).  All other reagents were obtained from Merck (Johannesburg, 
South Africa). 
Plant Material and Extract Preparation 
Different extracts of the bulbs were previously prepared from the plant (voucher DuToit2, 
NU) to investigate anti-inflammatory and antimicrobial activity (Du Toit et al., 2011).  An 
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aqueous extract was prepared by dissolving part of the dried and filtered crude material in 
water (10 mg/ml) by means of agitation. 
Cell Culture 
The human HepG2 hepatocellular carcinoma cell line was cultured in a humidified 
environment (37 °C; 95% O2, 5% CO2) to confluency in complete culture medium (CCM) 
consisting of Dulbecco‟s modified Eagle‟s medium supplemented with 10% (v/v) foetal 
bovine serum, 1% (v/v) L-glutamine and 1% (v/v) Penstrep-Fungizone® solution.  Cells were 
trypsinised and seeded according to the type of assay. 
Cell Viability 
Cell viability was measured using the methylthiazol tetrazolium assay.  Cells were seeded 
into a 96-well microtitre plate (15 000 cells/well) and treated in triplicate with varying 
concentrations of the extract in CCM for 24 hours.  The known cytotoxic drug emetine was 
used as a positive control.  Emetine is an alkaloid anti-amoebic drug which has been reported 
to enhance cytotoxicity (Lee & Wurster, 1995).  Thereafter, cells were incubated with a MTT 
salt solution (5 mg/ml in phosphate buffered saline (PBS)) and incubated (4 h; 37 °C).  
Culture fluid was then aspirated and dimethyl sulphoxide (DMSO) (100 l/well) was added 
to lyse the cells and the plate was incubated (1 h; 37 °C).  Optical density was measured (570 
nm; reference 690 nm) with an ELISA plate Reader (Bio-Tek Quant).  The concentration of 
the extract that reduced cell viability to 50% (IC50) was determined and used as a reference 
concentration to investigate potential mechanisms of cytotoxicity.  Cells were treated with the 
extract (0.03 mg/ml; 24 h; 37 °C) in CCM and seeded according to the type of subsequent 
assay.  The negative control was untreated cells that received CCM only. 
Metabolic Activity 
Changes in energy exchange required to drive cellular processes were investigated by 
determining the intracellular ATP concentration with a CellTiter-Glo® kit (Promega, 
Madison, WI, USA).  Treated cells were seeded into a white luminometer plate (20 000 
cells/well) in duplicate followed by the addition of 10 l/well of the supplied reagent.  The 
plate was agitated and incubated in the dark (10 min; room temperature) to lyse the cells.  
Thereafter, the luminescent signal was measured on a microplate luminometer (Turner 
Biosystems, USA).  The ATP concentration was expressed as Relative Light Units (RLU). 
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Phosphatidylserine Externalisation 
The loss of cell membrane asymmetry and subsequent phosphatidylserine externalisation 
during apoptosis was determined by measuring the amount of annexin-V bound to 
phosphatidylserine.  An Annexin-V-FITC kit (Roche Diagnostics, Penzberg, Germany) was 
used according to the manufacturer‟s instructions.  Briefly, 500 000 cells per condition were 
transferred into polystyrene cytometry tubes.  Cells were stained with 100 l of the Annexin-
V-FLUOS labelling solution and incubated in the dark (15 min; room temperature).  Flow 
cytometry analysis was conducted using a FACS Calibur flow cytometer (BD Biosciences, 
Johannesburg, South Africa) set at an excitation wavelength of 488 nm.  Data was collected 
from 2 500 events per sample in duplicate and cells were gated to exclude necrotic cells. 
Caspase-8 and -9 Activity 
The activity of the initiator caspases of apoptosis, caspase-8 and -9, were investigated 
using the Caspase-Glo® 8 and Caspase-Glo® 9 assay kits respectively (Promega).  Reagents 
were prepared according to the manufacturer‟s instructions.  Briefly, cells were seeded into a 
white luminometer plate (20 000 cells/well) in duplicate followed by the addition of 10 
l/well of either the Caspase-Glo® 8 or Caspase-Glo® 9 reagent.  The plate was agitated 
(300-500 rpm; 30 s) and incubated in the dark (30 minutes; room temperature).  
Luminescence was measured on the microplate luminometer and activity expressed as RLU. 
Mitochondrial Membrane Depolarisation 
An increase in mitochondrial membrane depolarisation and subsequent decrease in 
mitochondrial membrane potential, which contribute to mitochondrial dysfunction in 
apoptosis was investigated by measuring fluorescence of the cationic lipophilic dye 5,5′,6,6′-
tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine (JC-1) as part of the JC-1 
Mitoscreen assay (BD Biosciences).  Briefly, 500 000 cells per condition were transferred 
into polystyrene cytometry tubes.  Cells were incubated with 150 l/condition of the JC-1 dye 
(10 min; 37 °C).  Thereafter, cells were washed in JC-1 wash buffer, centrifuged (400 g; 5 
min) and resuspended in 300 l of flow cytometry sheath fluid.  Flow cytometry analysis was 
conducted using the FACS Calibur flow cytometer set at an excitation wavelength of 488 nm.  
Results were expressed as a percentage of depolarised mitochondria contained in the cells. 
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Oxidative Damage 
Lipid peroxidation of membrane fatty acids by free radicals caused by the extract was 
investigated by measuring the concentration of the end product malondialdehyde (MDA) 
using a thiobarbituric acid-butylated hydroxytoluene solution.  Following treatment of the 
cells, 200 l culture medium per condition was aspirated and dispensed into glass tubes.  
Each tube received 200 l of 2% (v/v) H3PO4, 400 l of 7% (v/v) H3PO4 and 400 l of 1% 
(v/v) thiobarbituric acid + 0.1 mM butylated hydroxytoluene solution.  A positive control of 
1% MDA was prepared, as well as a blank negative control containing 400 l of 3 mM HCl 
in place of the thiobarbituric acid + butylated hydroxytoluene solution.  Solutions were 
adjusted to pH 1.5 and heated in a water bath (15 min; 100 °C).  Once cooled to room 
temperature, 1.5 ml of butanol was added into each tube.  Samples were allowed to settle 
after vortexing and 500 l of the butanol phase from each tube was transferred to Eppendorf 
tubes and centrifuged (13 200 rpm; 6 min; 24 °C).  Thereafter, 100 l of the sample and 
controls was transferred into a 96-well microtitre plate in duplicate and the optical density 
was measured (532 nm; reference 600 nm) using the ELISA plate reader.  Results were 




The potential genotoxic effects of the extract were investigated using the alkaline comet 
assay (Singh, McCoy, Tice, & Schnyder, 1988), with minor modifications.  The known 
promutagen cyclophosphamide (10 M) was used as a positive control (Yusuf et al., 2000).  
Subsequent to treatment of the cells, the culture medium was aspirated and cells were rinsed 
three times with PBS, trypsinised and transferred to 15 ml Sterilin tubes.  The tubes were 
centrifuged (400 g; 10 min; 24 °C), the supernatants aspirated and cells were resuspended in 
PBS.  Duplicate slides of cells treated with the extract and respective controls were prepared 
using low melting point agarose and subjected to electrophoresis.  Digital pictures were taken 
with an Olympus IX5I fluorescent microscope (Olympus America Inc., PA, USA).  
Randomly selected comets (40 comets/slide) from each condition were scored and DNA 
migration analysed using the Comet Assay IV® software (Perspective Instruments Ltd., 
Suffolk, UK). 
CYP3A4 Activity 
The effect of the extract on the activity of the CYP3A4 subfamily of hepatic enzymes was 
investigated using the P450-Glo™ 3A4 assay kit (Promega) according to the manufacturer‟s 
The toxicological properties of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) in cultured HepG2 liver cells 86 
instructions.  The reconstituted luciferin detection reagent and luciferin-PFBE substrate 
solution were prepared prior to the assay.  Cells were seeded into a white luminometer plate 
(20 000 cells/well) in triplicate and allowed to attach overnight.  Cells were then treated with 
the extract or the known inducer dexamethasone (50 M), used as a positive control (Pascussi 
et al., 2001).  Following the incubation, the culture medium was aspirated and 50 l of the 
luciferin-PFBE substrate (in CCM) was added to each well such that a final concentration of 
50 M was obtained in the wells.  Cells were then incubated (4 h; 37 °C).  Thereafter, 50 l 
of the luciferin detection reagent was added and allowed to react by briefly agitating the 
plate.  The plate was allowed to equilibrate in the dark (20 min; room temperature).  
Luminescence was measured on the microplate luminometer and activity expressed as RLU. 
Statistical Analysis 
Data are reported as the mean  standard error of the mean.  GraphPad Prism (version 
5.02; GraphPad Software, San Diego, CA, USA) was used to determine the IC50 through non-
linear least squares regression with variable slope.  Statistical comparisons were made by 
one-way ANOVA followed by Bonferroni‟s post-test or by Student‟s two-tailed unpaired t-
test to determine p values.  A value of p < 0.05 was considered significant. 
Conclusions 
There was evidence that an aqueous extract prepared from the bulbs of S. nervosa was 
hepatotoxic in vitro.  It has the potential to induce apoptosis via the extrinsic apoptotic 
pathway.  There was also evidence of genotoxicity, possibly as a result of oxidative stress.  
CYP3A4 activity was slightly induced although it was not statistically significant.  There 
should be better awareness of the potential toxic effects of traditional medicine. 
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Table 1.  Caspase-8 and -9 activities (RLU) that were measured in HepG2 cells after 
treatment with the negative control or extract. 
Caspase Negative control (RLU) Extract (RLU) 
8 16 129  68 21 425  39 (↑ 1.3-fold; p < 0.001) 
9 492 443  2 522 440 190  1 545 (↓ 1.1-fold; p < 0.01) 
 
Table 2.  Changes in the Olive tail moment (OTM), tail extent moment (TEM), tail length 
(TL) and % tail length/head length (%TL/HL) of HepG2 cells treated with the extract or 
positive control cyclophosphamide for 24 h when compared to the negative control. 
Parameter Extract Cyclophosphamide 
OTM ↑ 3.7-fold (p < 0.05) ↑ 9.6-fold (p < 0.01) 
TEM ↑ 9.5-fold (p > 0.05) ↑ 11.8-fold (p < 0.05) 
TL ↑ 3.4-fold (p < 0.01) ↑ 3.5-fold (p < 0.01) 
%TL/HL ↑ 2.5-fold (p < 0.05) ↑3.1-fold (p < 0.05) 
 
Table 3.  CYP3A4 activity (RLU) in HepG2 cells treated with the extract or positive control 
dexamethasone for 24 h when compared to the negative control. 
Negative control (RLU) Extract (RLU) Dexamethasone (RLU) 
2 252  96.5 2 694  193.4 (↑ 1.2-fold; p > 0.05) 2 263  21.0 (p > 0.05) 
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Appendix 2 (Abstract – School Research Symposium) 
Students: 
Docrat FS; Ganie F; Mnaheni X; Mohamed S; Mohanlall S; Mseleku S; Mthethwa SF; 
Naidoo K 
Title: 
The cytotoxic effects of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) aqueous extract on 
cultured human oesophageal carcinoma cells 
Aims: 
Scilla nervosa (Burch.) Jessop (Hyacinthaceae), commonly known in isiZulu as „ingcino‟, is 
widely distributed throughout the eastern parts of Southern Africa.  The bulbs have long been 
used as decoctions in traditional medicine to treat constipation, dysentery, female infertility, 
nervous conditions in children and pain associated with rheumatic fever.  A previous study by 
our laboratory has shown that extracts prepared from the bulbs exhibited potent antimicrobial 
and anti-inflammatory activities that would therefore rationalise the traditional use of the 
plant.  Studies have also indicated that the bulbs contain homoisoflavanones and stilbenoids 
such as resveratrol and rhapontigenin that could be responsible for the therapeutic effects.  
Currently it is unknown whether the bulbs possess anticancer properties, and if so, what the 
possible nature of the mechanism(s) is. 
Methods: 
Cell Culture: The human oesophageal carcinoma cell line SNO was incubated (95% O2; 5% 
CO2; 37 °C) to confluency in DMEM supplemented with 5% foetal calf serum, 1% L-
glutamine and 1% Penstrep Fungizone.  Cytotoxicity: Cells were incubated with an aqueous 
extract (varying concentrations; 24 h) and viability was measured using the methylthiazol 
tetrazolium (MTT) assay.  Emetine was used as a positive control (1 g/ml).  The IC50-value 
was calculated and used as a reference to investigate the mechanism.  DNA damage: After 
treatment, single cell gel electrophoresis (comet assay) with fluorescent DNA staining was 
employed to determine double and single strand DNA breaks.  Cyclophosphamide was used 
as a positive control (10 M).  The comets formed were analysed with Comet IV® software 
and the olive tail moment (OTM), tail extent moment (TEM), tail length (TL) and % tail:head 
ratio (%T/H) were determined.  GraphPad Prism software was used to graph and analyse the 
data. 
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Results: 
Treatment with an aqueous extract of the bulbs resulted in a concentration-dependent 
decrease in cell viability and the IC50 = 0.08  0.014 mg/ml.  Emetine significantly reduced 
viability to 35.3  2.7% (p < 0.001).  DNA damage was detected with the extract (OTM 
increased 4.6-fold, p > 0.05; TEM increased 4.1-fold, p < 0.05; TL increased 2.4-fold, p < 
0.01; %T/H increased 1.4-fold, p > 0.05) and cyclophosphamide (OTM increased 7-fold, p < 
0.05; TEM increased 6-fold, p < 0.01; TL increased 2.3-fold, p < 0.01; %T/H increased 1.7-
fold, p > 0.05). 
Discussion and Conclusion: 
These results demonstrate that an aqueous extract from the bulbs of S. nervosa exhibits 
cytotoxicity with DNA damage towards a cancer cell line and suggest that it may have 
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Appendix 3 (Abstract – International Conference) 
The Effects of Scilla nervosa (Burch.) Jessop (Hyacinthaceae) aqueous extract on 
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Purpose 
Scilla nervosa, a medicinal plant indigenous to Southern Africa, is traditionally used to treat a 
diverse range of illnesses.  The Zulu people use aqueous decoctions of the bulbs as analgesics 
in the treatment of rheumatic fever (Bangani et al., 1999).  Bulbs have been identified to 
contain homoisoflavanones and stilbenes (Du Toit et al., 2010).  It has been recently 
demonstrated in our laboratory that extracts prepared from the bulbs possess potent anti-
inflammatory properties (Du Toit et al., 2011) and these findings therefore rationalise the 
traditional use of the plant as an anti-inflammatory agent.  However, little information is 
known about the plant‟s toxicity and only one historical report suggested 0.5-1 kg of the fresh 
plant in the flowering stages was toxic to sheep (Van der Walt and Steyn, 1946).  Therefore, 
current research is required into the potential toxicity of the bulbs on the liver as a major 
detoxifying organ. 
In this study we investigated the effects of an aqueous extract of the bulbs in cultured Hep G2 
human liver cells, a model system for liver metabolism and toxicity of xenobiotics. 
Methods 
Cytotoxicity—Hep G2 cells were cultured to confluency, incubated with the extract (varying 
concentrations; 24 h) and viability was measured using the MTT assay.  The IC50-value was 
determined and used as a reference concentration in the subsequent assays.  DNA Damage—
Single cell gel electrophoresis with fluorescent DNA staining was employed to determine 
single strand DNA breaks.  Oxidative Damage—Lipid peroxidation was measured by 
quantifying the levels of malondialdehyde in a colorimetric assay.  Apoptosis—The apoptotic 
potential was determined using fluorescence-activated cell sorting (FACS) and luminometry 
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with commercial annexin-V-FITC and Caspase-Glo 8/9 assays, respectively.  Mitochondrial 
Membrane Potential—FACS and the commercial JC-1 Mitoscreen assay was used. 
Results and Discussion 
The cell viability of Hep G2 cells showed a dose-dependent decrease and the IC50 for the 
extract was determined as 0.03 mg/ml.  DNA fragmentation, as evidenced by an increase in 
tail length, was more pronounced in the treated cells.  Lipid peroxidation increased 2-fold.  
The percentage of apoptotic cells was higher than the controls, and the intracellular activities 
of caspase-8 (1.3-fold) and ATP (1.2-fold) increased, while caspase-9 decreased (1.1-fold).  
There was no change in mitochondrial membrane depolarisation.  Results suggest that liver 
cells are sensitive to an aqueous extract of the bulbs of S. nervosa.  Future research could be 
directed towards determining the effects in vivo.  Our results and future studies would support 
the policies of the government and United Nations which aim to promote the development, 
use and regulation of traditional medicine. 
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